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CHAPTER I  
Introduction 
 
 
Bacterial infections continue to affect human and animal health contrary to the 
notion that the advent of antibiotics would result in their decline or eradication. It has 
been estimated that about 1.5 billion people contract bacterial infections each year 
worldwide and that 70% of these infections result from ingestion of contaminated food. 
In the US alone, food-borne bacteria affect about 33 million people annually resulting in 
about 10000 deaths and costing the US economy $9.3-12.8 billion every year (Deisingh 
& Thompson 2004).   
 
Apart from food borne bacterial infections, there has been an increase in number 
of cases of tuberculosis, sexually transmitted diseases and meningitis (Deisingh & 
Thompson 2004). Further, opportunistic bacteria contribute to a significant number of 
infections in individuals immunocompromised due to HIV infection. In addition, many 
bacterial pathogens are considered to be potential biological warfare/bioterrorism agents 
due to their extreme infectivity and are included in the category of select agents by the 
Centers for Disease Control and Prevention. These agents include Bacillus anthracis 
(anthrax), Clostridium botulinum toxin (botulism), Francisella tularensis (tularemia), 
Yesinia pestis (plague) and many other bacteria.  Recent anthrax attacks through 
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contaminated postal mails in the US reaffirm their potential use in bioterrorism (Valiante 
et al. 2003).  
 
The control and prevention of bacterial infections depends on our ability to detect 
bacteria from environmental samples and identify persons exposed to pathogenic 
bacteria. It is essential to rapidly and accurately detect and identify a bacterial agent used 
in case of an act of bioterrorism to prevent adverse consequences. On the other hand, 
constant monitoring and surveillance of bacterial infections in a population will help in 
their prevention and eradication. Currently, various methods are available for the 
detection of bacteria or diagnosis of bacterial infections. These include isolation and 
identification of bacteria, detection of bacterial nucleic acids (PCR and DNA 
microarrays) and bacterial antigens/whole bacteria (immunoassays and biosensors) and 
disease diagnosis based on indirect methods such as demonstration of specific antibodies 
(immunoassays). Isolation and identification of bacteria is very laborious and time-
consuming and some bacteria are fastidious in nature requiring special growth conditions 
and grow slowly. Although the detection of nucleic acid using either PCR or microarrays 
is more sensitive and rapid, the methods are expensive. Antibodies used in biosensors and 
immunoassays for the detection of bacteria are expensive to produce and are not stable. 
These limitations of current methods necessitate either improving the existing methods or 
developing novel methods for the detection of bacteria and diagnosis and monitoring of 
bacterial infections.  
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Antibodies have been in use in a wide range of applications as analytical agents. 
Polyclonal sera were used as the source of antibodies before the development of 
hybridoma technology (Kohler & Milstein 1975). Monoclonal antibodies produced 
through the hybridoma technology have found applications in research, diagnostics, 
biosensors and therapeutics. Monoclonal antibodies are superior to polyclonal antibodies 
and can be produced in relatively large quantities. However, they suffer from some 
limitations such as high cost of production, variation from batch to batch, sensitivity to 
temperature, etc. In vitro selected nucleic acid probes known as aptamers have potential 
applications as analytical reagents that are based on molecular recognition. Aptamers 
(Latin ‘aptus’ meaning ‘to fit’) are single stranded oligonucleotides that are selected 
through an in vitro process known as SELEX (Systematic Evolution of Ligands by 
EXponential enrichment) for specific binding to a target of interest (Ellington & Szostak 
1990; Tuerk & Gold 1990).   
 
Enizyme linked immunosorbent assay (ELISA) is a sensitive and rapid method 
and has been employed in a wide range of applications such as detection and 
quantification of proteins, tumor markers, antibodies and other analytical applications. 
However, in the present form microtiter plate-based ELISA suffers from limited 
throughput and requires a large quantity of reagents and samples. The advent of 
microarray technology has revolutionized the field of genomics. The technology is being 
rapidly expanded into other areas such as proteomics, glycomics and metabolomics and 
even clinical medicine. Microarray based immunoassays are multiplex in nature and 
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require small quantities of reagents and samples. Antigen microarrays will allow rapid 
screening of clinical sample against multiple antigens and require small quantity of 
samples (Bacarese-Hamilton et al. 2004).  
 
The objectives of the present study are 
1. To select ssDNA aptamers against a surface target of Francisella tularensis for 
possible use in diagnostics and biosensors. 
2. To develop lipopolysaccharide microarrays for the detection of antibodies.  
3. To develop intact whole bacterial cell arrays for the detection and characterization 
of antibodies to surface antigens.  
 The latter two objectives are expected to aid in rapid disease diagnosis and 
seroepidemiological studies.  
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 CHAPTER II 
 
Review of literature  
 
Francisella tularensis 
 
 Francisella tularensis, the causative agent of the zoonotic disease tularemia, is a 
Gram negative, facultative intracellular bacterium. The organism was first isolated in 
1911 from rodents affected with a  plague-like disease in Tulare County, California and 
named Bacterium tularensis (Ellis et al. 2002).  Many vertebrates including mammals, 
birds, amphibians, and fish and even invertebrates are naturally infected with F. 
tularensis. Tularemia is restricted to the northern hemisphere for reasons unknown 
(Johansson et al. 2004b) and is known by many names such as rabbit fever, hare fever, 
deerfly fever and lemming fever (Ellis et al. 2002). 
 
Francisella tularensis belongs to the genus Francisella within the family 
Francisellaceae. The strains of F. tularensis differ in biochemical properties, geographic 
distribution and virulence and are accordingly grouped into one of the four now well 
recognized subspecies: F. tularensis subsp. tularensis (type A F. tularensis), subsp. 
holarctica (type B F. tularensis), subsp. mediasiatica, and subsp. novicida. The 
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subspecies of F. tularensis exhibit a close phylogenetic relationship and are antigenically 
similar (Broekhuijsen et al. 2003). Francisella philomiragia the only other member of the 
genus Francisella, is an opportunistic pathogen causing disease in immunocompromised 
individuals and is often associated with water.   
 
Strains of F. tularensis subsp. tularensis (type A F. tularensis) are highly virulent 
for humans and are reported from North America and recently from Europe (Ellis et al. 
2002). It has been reported that as few as ten organisms can cause severe illness and 
death in humans (Sjostedt 2003). Infections with type A F. tularensis resulted in 5 to 
30% mortality before the advent of effective antibiotics (Titball et al. 2003). Strains 
belonging to subsp. holarctica and mediasiatica are moderately virulent for humans, 
causing a similar infection but without a significant mortality (Titball et al. 2003).  F. 
tularensis subsp. holarctica is mainly reported from North America and Eurasia. F. 
tularensis subspecies mediasiatica is prevalent in the former Soviet Union (Ellis et al. 
2002). Strains of F. tularensis subsp. novicida are primarily found in North America and 
reported to cause infections in immunocompromised individuals (Ellis et al. 2002; Titball 
et al. 2003).  
 
Tularemia occurs in many forms in humans depending on the route of entry and 
the strain of F. tularensis involved. The ulceroglandular form of tularemia is the most 
common form and occurs when the organism enters through cutaneous route, either 
through a wound infection or an insect bite.  Involvement of virulent strains of F. 
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tularensis subspecies tularensis results in an acute septicemic form of the disease 
‘typhoidal tularemia’.  Ingestion of contaminated food or drinking water containing F. 
tularensis results in oropharyngeal or gastrointestinal form of tularemia. The most severe 
form of the disease occurs when organisms are inhaled resulting in pneumonic form of 
tularemia (Ellis et al. 2002; Johansson et al. 2004b).  
 
 Francisella tularensis is considered to be a potential biological weapon owing to 
its extreme infectivity, ease of dissemination after aerosolisation, and its ability to cause 
illness and death. The organism is very hardy and survives for weeks at low 
environmental temperatures, making it an ideal agent for bioterrorism. Aerosol 
dissemination of F. tularensis in a populated area would be expected to cause a large 
number of acute cases in 3 to 5 days, with overwhelming medical and public health 
consequences. For these reasons F. tularensis is considered as a category A agent 
(Dennis et al. 2001). In the event of use of F. tularensis in bioterrorism, rapid detection 
of organisms in environmental samples becomes crucial for containment and clean-up 
efforts. Simple, rapid and reliable diagnostic tests need to be developed to screen persons 
exposed to the pathogen. 
 
The laboratory diagnosis of tularemia is based on isolation and identification of 
the organism, demonstration of antigen or antibodies using immunoassays, or detection 
of nucleic acid. Culturing of F. tularensis is generally avoided, as the organism is 
fastidious and slow growing under laboratory conditions and extensive precautions must 
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be taken to prevent infection of laboratory personnel. Organisms can be cultured directly 
from ulcer scrapings, lymph node biopsies, or sputum (Ellis et al. 2002; Johansson et al. 
2004b).   
 
Tularemia can be diagnosed by the detection of antigens from clinical samples. 
An antigen capture ELISA has been described that can detect bacteria using antibodies 
specific for lipopolysaccharide of F. tularensis LVS (Live Vaccine Strain). The 
antibodies used in the assay specifically recognized type A and type B F. tularensis with 
the detection limit of 103 to 104 bacteria per ml (Grunow et al. 2000). An 
immunochromatographic hand-held assay has been developed based on antibodies to LPS 
of F. tularensis LVS. The sensitivity of the assay was reported to be 106 bacteria per ml 
in PBS and 106 to 107 bacteria per ml in spiked human serum (Grunow et al. 2000). The 
time required for this assay is approximately 15 min, but the sensitivity of the assay is not 
very high. Although LPS is a commonly targeted molecule as it is readily accessible on 
the surface of the bacterium and present in high copy number, antibodies directed against 
LPS of F. tularensis LVS do not discriminate between highly virulent type A F. 
tularensis and less virulent type B F. tularensis. Antigens specific for various subspecies 
of F. tularensis have been recently identified (Hubalek et al. 2003).  
 
 Tularemia is frequently diagnosed based on the clinical picture and serology as 
isolation of the organism is difficult. The presence of antibodies against F. tularensis is 
detected by immunoassays such as agglutination tests or ELISA (Carlsson et al. 1979; 
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Koskela & Salminen 1985; Syrjala et al. 1986). Specific antibodies against F. tularensis 
appear in serum in about 10 to 14 days after the onset of infection. Tularemia can be 
diagnosed by detecting antigen in human urine samples, but the method is not routinely 
used (Tarnvik et al. 1987; Johansson et al. 2004b).  
 
A number of PCR based methods have been described for the detection of F. 
tularensis and diagnosis of tularemia. These assays are highly sensitive and can 
discriminate the subspecies of F. tularensis (Ellis et al. 2002; Johansson et al. 2004b).  
These assays use primers directed against the outer membrane proteins such as fopA 
(Fulop et al. 1996) or the 17-kDa outer membrane lipoprotein (Junhui et al. 1996; 
Grunow et al. 2000). The detection limit of these assays is 102 bacteria per ml in PBS and 
103 to 104 bacteria per ml in spiked serum (Grunow et al. 2000). A nested PCR is 
reported to be capable of detecting 1 CFU (Colony Forming Unit) of F. tularensis (Fulop 
et al. 1996). However, some compounds present in clinical samples inhibit PCR affecting 
the sensitivity of these assays. Also some preparation of sample is required to achieve 
greater sensitivity with PCR (Fulop et al. 1996; Grunow et al. 2000).  
 
PCR-based methods show greater sensitivity compared to other methods even in 
their current form. A PCR assay positively identified 73% of serologically confirmed 
cases of human ulceroglandular tularemia, whereas bacteria could be isolated from only 
25% of these patients (Sjostedt et al. 1997). Real-time PCR based methods have also 
been described for the detection of F. tularensis from infected tissues and environmental 
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samples (Higgins et al. 2000; Versage et al. 2003; Emanuel et al. 2003; Lamps et al. 
2004). RT-PCR is about 10 times more sensitive than the standard PCR, detecting 10 to 
100 bacteria per ml. Also RT-PCR is more rapid than the conventional PCR requiring 
only minutes to a few hours.  The usefulness of PCR based methods is established for 
clinical diagnosis of the ulceroglandular form but not for respiratory or oropharyngeal 
forms of tularemia (Johansson et al. 2004b).  
 
Many PCR methods have been developed to discriminate the subspecies of F. 
tularensis. A PCR has been developed that can differentiate type A F. tularensis from 
type B F. tularensis based on one base difference in the 16S rRNA (Forsman et al. 1994). 
Various genetic typing methods such as pulsed-field-gel-electrophoresis (PFGE), 
arbitrary primed PCR (AP-PCR), multiple locus sequence typing (MLST), microarray 
analysis, insertion sequence probed restriction fragment length polymorphism (IS-RFLP), 
amplified fragment length polymorphism (AFLP) and multiple-locus variable-number 
tandem repeat analysis (MLVA) have been applied to discriminate F. tularensis 
subspecies (Johansson et al. 2004b).  Among these techniques MLVA is highly 
discriminatory and can be used to distinguish individual isolates of F. tularensis 
(Johansson et al. 2004a).  
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Aptamers 
 
 
Aptamers are single-stranded oligonucleotides that are selected in vitro for 
specific binding to a target of interest. Aptamers have been selected against a variety of 
targets such as simple ions, small molecules, peptides, single proteins, organelles, 
viruses, and even whole cells (Wilson & Nock 2002). Aptamers consist of RNA, ssDNA 
or modified nucleotides and are usually 15 to 60 nucleotides long. The binding affinity of 
aptamers range from KD’s of 1 ρM to 1 µM with the majority in the range of 1 – 10 ηM. 
The word aptamer is derived from Latin word “aptus” meaning “to fit”. Aptamers are 
selected from a pool of nucleotide templates consisting of random sequences by an in 
vitro selection process known as SELEX (Systematic Evolution of Ligands by 
EXponential enrichment).  SELEX process was independently developed by three 
laboratories in 1990 (Robertson & Joyce 1990; Ellington & Szostak 1990; Tuerk & Gold 
1990). Aptamers are versatile molecules and have the potential to be developed into 
novel diagnostic, therapeutic and enzyme (ribozymes) systems. 
 
Aptamers have several advantages over antibodies. The selection of aptamers is 
completely an in vitro process and it does not involve animals, cells or in vivo conditions. 
Therefore the properties of aptamers can be changed as required. Aptamers could be 
selected to function in non-physiological conditions such as non-physiological pH or 
temperature. Similarly, the kinetic parameters of aptamers such as on-rate and off-rates 
can be changed as desired. Unlike antibodies, aptamers can be generated against 
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molecules such as toxins or molecules that are inherently poor immunogens. Once 
selected, aptamers can be inexpensively synthesized using nucleic acid techniques with 
little or no batch-to-batch variations. Reporter molecules such as fluorophores and biotin 
can be incorporated during synthesis without compromising the function of aptamers. 
Aptamers are stable and can be stored at room temperature. Aptamers do undergo 
denatuaration but it is reversible unlike that of antibodies (Jayasena 1999).  
 
SELEX involves screening of a large combinatorial oligonucleotide library by an 
iterative process of in vitro selection and amplification in order to find sequences of 
desired properties (Figure 1). Typically a SELEX process starts with design and 
combinatorial chemical synthesis of a random DNA library. These sequences will have a 
randomized region flanked by fixed regions for PCR amplification during the selection 
process.  The molecular diversity of these libraries is determined by the number of 
randomized bases in the library. In an oligonucleotide library with 30 randomized 
nucleotides, the number of possible individual unique sequences would be 1018 
(430=1018). However, in practice the diversity of these libraries is determined by the scale 
of solid–phase DNA synthesis and libraries with a diversity of 1014 to 1015 individual 
sequences are usually used. Diversity of oligonucleotide libraries used in SELEX 
experiments exceed the diversity of antibodies that can be generated by the immune 
system. The chances of finding specific and high-affinity aptamers against a target 
increases with the diversity of library.  
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The selection process involves incubation of the library with a target of interest 
under defined conditions such as buffer, pH and temperature. After incubation, 
oligonucleotide sequences that specifically interact with the target will be separated from 
the rest of the library, amplified, and used in the next round of selection. Normally 
nitrocellulose filter partitioning is used for protein targets to separate the sequences that 
interact with the target. The whole process of selection and amplification will be repeated 
typically 8 -15 cycles until the library becomes enriched. The selected pool is tested for 
its enrichment using binding assays. The enriched library is cloned and sequenced. 
Individual selected sequences are further characterized for their binding specificity and 
affinity.  
 
The selection of RNA aptamers is similar to that of DNA aptamers except for 
minor modifications. A promoter for an RNA polymerase is engineered within a fixed 
region of the library to allow in vitro RNA synthesis. After each selection step with the 
RNA library, the library is amplified by RT-PCR and later in vitro transcribed to generate 
a pool of RNA for next round of selection. DNA aptamers are relatively stable compared 
to RNA aptamers. The presence of 2’ hydroxyl of groups on ribose renders the RNA 
susceptible to breakdown by endonucleases such as RNase (Sampson 2003). 
Alternatively, RNA sequences compared to DNA sequences enrich the diversity of 
libraries by increasing the variety of folded structural motifs. The presence of 2’-
hydroxyls may increase the stability of tertiary structure in RNA by helping in 
interdomain interactions (Gallo et al. 2003).   
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Aptamers (RNA and ssDNA) have the ability to form three dimensional structural 
conformations through intramolecular interactions. Unlike nucleic acid-nucleic acid 
interactions that involve base-base complementarity, aptamers recognize their targets 
through molecular shape complementarity (Hermann & Patel 2000). This recoginiton is 
stabilized by forces such as electrostatic interactions, hydrogen bonding, and stacking of 
flat moieties. Aptamers show a high degree of specificity  to their targets sometimes that 
may exceed antibody specificity (Jayasena 1999). The high specificity is a result of 
selective pressure in the SELEX experiment. They can discriminate molecules based on 
subtle changes such as the presence or absence of methyl or hydroxyl groups.  The high 
binding affinity and specificity of aptamers toward their targets is achieved by enclosing 
large parts of the target by aptamers (Hermann & Patel 2000). Although aptamers have 
been selected against a wide range of targets, the affinity of aptamers is influenced by the 
properties of targets. Molecules with hydrogen bond donors or acceptors, flat moieties 
(planarity), and positively charged groups make better targets for aptamers.  Non-planar 
molecules with a neutral to net negative charge or  a highly hydrophobic nature are poor 
targets for aptamers (Wilson & Nock 2002).  
 
 Aptamers as analytical agents could be developed into novel diagnostics and 
biosensors. Aptamers offer several advantages over antibodies (Jayasena 1999; 
O'Sullivan 2002). A biosensor was developed for human thrombin using a ssDNA 
aptamer that could detect as low as 0.7 amol of thrombin using evanescent-wave-induced 
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fluorescence anisotropy (Potyrailo et al. 1998).  A DNA aptamer was incorporated in an  
affinity probe capillary electrophoresis to quantify human IgE with a detection limit  of 
46pM (German et al. 1998). An aptamer specific for L-selectin was incorporated into the 
stationary phase of an affinity chromatography column and used to purify recombinant L-
selectin-Ig fusion protein produced in Chinese hamster ovary cells (Romig et al. 1999). 
Aptamer-based biosensor arrays have been developed by immobilizing fluorescently 
labeled aptamers onto a glass substrate. The array was used to detect and quantify tumor 
markers from a complex mixture of biomolecules (McCauley et al. 2003).  Additionally, 
aptamers have been engineered into beacons (stem-loop structure with a fluorophore on 
one arm of the stem and a quencher on the other) for the detection of targets without the 
need to wash off unbound aptamers (Hamaguchi et al. 2001; Li et al. 2002). An RNA 
aptamer was incorporated into an affinity capillary electrophoresis/laser-induced 
fluorescence assay for detection of reverse transcriptase (RT) of the type 1 human 
immunodeficiency virus (HIV1). While the detection limit for the assay was 50nM 
(6µg/ml), presence of undiluted cell culture media interfered with the assay necessitating 
the dilution of culture media at least 100-fold (Pavski & Le 2001).  
 
Although described as “emerging molecules that rival antibodies in diagnostics” 
(Jayasena 1999), aptamers have found very few applications in diagnostics and continue 
to be mainly a subject of academic interest (Hesselberth et al. 2000a). Aptamers could be 
used as capture or reporter molecules or in combination with antibodies for the detection 
of analytes in a sandwich-type Enzyme linked oligonucleotide assay (ELONA) analogous 
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to ELISA (O'Sullivan 2002).  An aptamer-based magnetic bead-
electrochemiluminescence assay has been developed for the detection of anthrax spores 
with a dynamic range equivalent to <10 to >6x106 spores (Bruno & Kiel 1999). DNA 
aptamers against E. coli O111:B4 LPS conjugated to quantum dots were employed for 
the detection of the bacteria. A shift in fluorescence emission was observed upon binding 
of bacteria to quantum dot-aptamer conjugate. Although this is a homogenous assay 
without the need for wash steps, the study did not report the detection limit of bacteria 
(Dwarakanath et al. 2004). DNA aptamers were developed against cholera toxin and 
Staphylococcal enterotoxin B by conjugating these toxins to tosyl-activated magnetic 
beads. These toxins could be detected in the low nanogram to picogram ranges by 
employing selected aptamers in electrochemiluminescence and colorimetric microplate 
assays (Bruno & Kiel 2002). Further a DNA spiegelmer (mirror-image aptamer) was 
developed against staphylococcal enterotoxin B. Initially, a D-peptide corresponding to a 
stable domain of 25 amino acids of whole protein (28 kDa protein consisting of 239 
amino acids) was used as the target for selection of D-DNA aptamer. The corresponding 
enantiomeric L-DNA spiegelmer recognized the full-length protein with a binding 
constant of ~ 420nM (Purschke et al. 2003). An RNA aptamer was selected against ricin, 
a class II ribosome inactivating protein and a potential biological warfare agent. The 
selected aptamer recognized the catalytic ricin A-chain (RTA) with a binding affinity of 
Kd = 7.3 nM and could compete with the natural substrate, the sarcin-ricin loop (SRL) of 
eukaryotic 23-28S rRNA.  The aptamer could be used as a diagnostic reagent for the 
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detection of ricin (Hesselberth et al. 2000b). RNA aptamers have been selected to the 
amyloid peptides of the Alzheimer’s disease (Ylera et al. 2002).  
 
Aptamers as therapeutics may be useful in the treatment of infectious diseases, 
cancer, cardiovascular diseases. Currently, three aptamers are being evaluated in clinical 
trails for inhibition of HIV replication, angiogenesis, and intimal hyperplasia (Nimjee et 
al. 2005). RNA aptamers selected against an invariant surface protein of African 
trypanosomes may be used as a therapeutic agent against the parasite (Homann & 
Goringer 1999).  Several properties of aptamers make them better therapeutic agents. 
Apart from exhibiting high specificity and affinity towards their targets, they lack 
immunogenicity. The activity of aptamers can be controlled using oligonucleotide 
antidote independent of biological clearance (Rusconi et al. 2002). Oligonucleotide 
antidotes inhibit aptamer binding to its target by altering the aptamer structure through 
Watson-Crick base paring. Further, aptamers can be modified to alter their bioavailability 
and pharmacokinetics properties. The use of modified nucleotides increases the stability 
of aptamers against nuclease degradation. The small size of aptamers results in faster 
renal clearance. However, modification of aptamers by conjugating to polyethylene 
glycol or dialkylglycerol or 3’-biotinylation or incorporation of aptamers into liposome 
slows down aptamers clearance (Wilson & Nock 2002; Rimmele 2003; Nimjee et al. 
2005). Furthermore, aptamers can be selected with specificity for ortholog proteins from 
two different species using toggle SELEX. Selection of an aptamer against a target of 
interest in humans and ortholog target from a species in which pre-clinical trials are 
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planned allows pre-clinical evaluation of aptamers. This is achieved by alternating the 
targets between human form and ortholog protein from other species during selection of 
aptamers.  
 
Some of the limitations associated with aptamers include their susceptibility to 
nucleases. A number of strategies have been developed to increase the stability of 
aptamers. The use of modified nucleotides such as pyrimidines with 2’-amino or – fluoro 
groups or substitutions of O’ methyl for OH group at 2’ position in purines after 
selection, enhance the stability of aptamers (Sampson 2003; Nimjee et al. 2005). The 
stability of aptamers can also be increased by modifying the phosphodiester backbone. 
The use of enantiomeric aptamers known as spiegelmers provides an alternative solution 
in increasing the stability of aptamers. Aptamers are initially selected against the 
chemical mirror image of the target (e.g. an unnatural D-amino acid peptide) and the 
selected aptamers are later converted into chemical mirror image of their own by 
substituting natural D-ribose with L-ribose to obtain spiegelmers (mirror–image 
aptamers). The selected spiegelmers recognize the original target because of molecular 
symmetry (Cerchia et al. 2002; Sampson 2003).  
  
The development of aptamers is influenced by the properties of a target. Some 
molecules are better targets for aptamers than the others. There is no standard selection 
method that can be applied to all targets, requiring adaptation of methods for each target 
in most cases. Generally, aptamers function well in the conditions in which they are 
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selected, and they invariably need certain concentrations of cations to fold into their 
active state.  These properties of aptamers may limit their use in certain applications 
(Rimmele 2003).  
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Lipopolysaccharide 
 
Lipopolysaccharides (LPS) are important antigens of Gram-negative bacteria 
(Jauho et al. 2000). They constitute the major components of the outer membrane of 
Gram-negative bacteria. Lipopolysccharides are amphipathic molecules consisting of 
three distinct regions: hydrophobic lipid-A, hydrophilic core region and polysaccharide 
O-antigen (Figure 2). LPS represents 10 to 15 percent of the surface molecules in the 
outer membrane and may cover up to 75% of the Gram-negative bacterial cell surface 
(Lerouge & Vanderleyden 2002; Caroff & Karibian 2003). Approximately 2 million 
molecules of LPS are estimated to be present on the surface of E. coli (Raetz 1990; 
Rietschel & Brade 1992).  LPS has been shown to be highly immunogenic and plays a 
major role in pathogenesis.  Lipid-A is highly conserved among Gram-negative bacteria, 
whereas the core region and O-antigen show genus and species/strain specificity, 
respectively (Lerouge & Vanderleyden 2002).  The diversity and specificity of O-antigen 
is attributed to its unique sugar composition and number of possible glycosidic linkages.  
The identification of Gram-negative bacteria is traditionally done by serotyping using 
antibodies specific for O-antigen. 
 
LPS is also known as endotoxin as it is responsible for the endotoxemia or sepsis 
associated with Gram-negative bacterial infections. The lipid-A part of LPS is 
responsible for its endotoxic activity. The structure of Lipid-A typically consists of a β-
D-GlcN-(1-6)-α-D-GlcN disaccharide backbone with two phosphoryl groups at positions 
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1 and 4’.  Up to four acyl chains are attached to the disaccharide backbone of lipid-A by 
amide or ester linkage. Further, these acyl chains may carry additional fatty acids so that 
their number can go up to seven in some LPS molecules. Lipid-A anchors LPS molecules 
into the outer membrane.  The number of acyl chains, their length and phosphorylation 
state of the disaccharide backbone influence the endotoxicity of lipid-A. The structure of 
lipid-A containing disaccharide backbone with six acyl chains, as in case of E. coli LPS, 
along with the two phosphate groups appeared to be essential for optimum recognition by 
mammalian receptors  for expression of endotoxic activity (Erridge et al. 2002).   
 
The core oligosaccharide consists of a small number of sugars that link lipid-A 
and O-polysaccharide. The core polysaccharide can be divided into inner core and outer 
core.  The inner core is proximal to lipid-A and consists of unusual sugars such as 3-
deoxy-D-manno-octulosonic acid (Kdo) and L-glycero-D-manno heptose (Hep). Kdo is 
seen in almost all LPS examined to date and is essential for the viability of bacteria. Kdo 
links the core to lipid-A through an acid-labile ketosidic linkage. Additionally, three to 
six sugars are present in the inner core. The outer core consists of more common sugars 
such as hexoses and hexosamines and is known as hexose region.  The structure of the 
core region is very much conserved within a genus.  
 
The O-polysaccharide, the outermost part of LPS, is attached to the core region 
and extends into the environment. O-polysaccharide consists of repeating subunits of 
hexoses and the number of sugars in each subunit varies from one to eight among 
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different bacteria. The number of subunits present in O-polysaccharide is between 0 and 
50. Lipopolysaccharides are heterogeneous molecules due to incomplete addition of O-
polysaccharide subunits.  The variable number of subunits is responsible for the 
characteristic ladder-like pattern of LPS observed on SDS-PAGE.  The O-polysaccharide 
is responsible for the diversity and specificity observed in LPS.  The structure and 
chemical composition of O-polysaccharide varies among strains and in some cases even 
within a strain. O-polysaccharide is the target for host antibody response to LPS and 
hence O-polysaccharide is also known as O-antigen. O-antigen serology has been used 
for typing Gram-negative bacteria. O-antigen also plays a role in the inhibition and 
activation of the complement system of the host (Erridge et al. 2002). In some bacteria 
such as Salmonell, O-antigen protects the bacteria by preventing the formation of 
membrane attacking complex (MAC) by the complement. The high structural diversity 
exhibited by O-antigen may possibly help bacteria to evade the immune system (Raetz 
1990). The presence of O-polysaccharide gives a smooth  appearance to bacterial 
colonies on agar plates resulting in so-called ‘smooth’ LPS (S-LPS) or LPS I. Mutant 
bacteria  having a ‘rough’ phenotype or R phenotype produce LPS II (lipid-A and core) 
that lacks O-polysaccharide.   
 
Lipopolysaccharide of F. tularensis has unusual biological properties unlike LPS 
from other bacteria. It does not exhibit endotoxic activity and is a poor inducer of 
proinflammatory cytokine responses (Sandstrom et al. 1992). This prompted the recent 
structural analysis of LPS of F. tularensis. The LPS contains a β-GlcN-(1-6)-GlcN lipid-
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A backbone with a number of unusual features. The lipid-A apparently has reducing 
glucosamine endgroup with no phosphate substituents and βGlcN does not contain 
substituents at O-3 and O-4. Some lipid-A in LPS preparations are found to be 
unsubstituted with Kdo. There is no substituent at O-4 of Kdo. The lipid-A possesses 
longer chain fatty acids compared to the highly toxic lipid-A of E. coli.  The LPS has a 
small core and the inner part of the core contains mannose rather than more common 
heptose. The unusual structural features of F. tularensis LPS could be responsible for the 
weak endotoxicity associated with the LPS (Vinogradov et al. 2002).  
 
The O-antigen structure of F. tularensis strain 15  and the Live Vaccine Strain 
(LVS) contains repeating tetra-saccharide subunits:  4-(α-D-GalpNAcAN-(1-4)-α-D-
GalpNAcAN-(1-3)-β-D-QuipNAc-(1-2)-β-D-Quip4NFo-1) (Vinogradov et al. 1991; 
Conlan et al. 2002).  Both the strains are empirically derived from type B F. tularensis. 
Lipopolysaccharides from type A and type B F. tularensis show serological cross 
reactivity and appear to be structurally related (Grunow et al. 2000; Conlan et al. 2002). 
The repeating units of the O-antigens from type A F. tularensis Schu S4 strain and LVS 
were presumed to be the same based on MALDI-MS analysis (Prior et al. 2003). LPS of 
F. tularensis subspecies novicida is biologically more active and immunochemically 
distinct from of LPS of type A and type B F. tularensis. The lipid-A from F. novicida 
LPS does not contain phosphate substituents and apparently contains a free reducing end. 
The core polysaccharide of F. novicida has an additional α-Glc residue compared to the 
core of F. tularensis (Vinogradov & Perry 2004).  The tetrasaccharide subunit of O-
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antigen of F. novicida shares a common disaccharide unit with that of F. tularensis 
(Vinogradov et al. 2004).  
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Microarray Technology 
 
The advent of microarray technology that allows the high-throughput study of 
molecule-molecule interactions has revolutionized the field of biomedical research. The 
technology is rapidly being expanded into many areas including clinical medicine. 
Microarrays were first used in immunological assays (Ekins 1989). However, the advent 
of genome sequencing coupled with high-throughput oligonucleotide synthesis and PCR 
resulted in its extensive use in the study of nucleic acid–nucleic acid interactions. DNA 
microarrays allow the gene expression study of thousands of genes in a single 
experiment. The technology is being increasingly used in the study of cell biology, 
cancer, inflammatory and metabolic disease and pathogenic microorganisms.  Further, 
DNA microarrays have potential applications in disease diagnosis and epidemiological 
studies.  
 
The level of mRNAs is not directly correlated to the amount or function of protein 
in a cell. Factors such as mRNA half-lives, efficiency of translation and post-translational 
modifications of proteins affect the amount and function of proteins in a cell. Therefore, 
it is difficult to draw meaningful conclusions on the amount or function of proteins in a 
cell based on the relative abundance of mRNAs (Howbrook et al. 2003). Protein and 
peptide microarrays allow the study of enzyme-substrate, DNA-protein and protein-
protein interactions (Templin et al. 2002). Protein and peptide arrays have been 
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generating vast amounts of information in the area of proteomics and have been helpful 
in overcoming some of the limitations of DNA microarrays.  
 
Many proteins undergo post-translational modifications that influence their 
functions. Some proteins and other biomolecules are conjugated to sugars and these sugar 
moieties are involved in molecular interactions. Further, the development of carbohydrate 
arrays benefit the study of interactions between sugars and proteins (Fukui et al. 2002; 
Wang et al. 2002; Willats et al. 2002). Carbohydrate microarrays have potential 
applications in functional glycomics, drug discovery and diagnois (Shin et al. 2005). 
Recently, a carbohydrate array has been developed to study the interaction between 
carbohydrate and cells and detect pathogens. Bacteria could be detected based on known 
carbohydrate binding epitope present on the surface of pathogens. Further, the study 
suggested the use of carbohydrate arrays for screening potential antiadhesion therapeutics 
against bacteria (Disney & Seeberger 2004).  
 
Transfected-cell microarrays allow the high-throughput identification of the 
cellular functions of genes. The microarrays are fabricated by printing cDNA in 
expression vectors in gelatin on microarray slides. The slides are briefly exposed to a 
lipid transfection reagent and placed in dishes; cells are then added onto the slides and 
allowed to form a confluent lawn. The cells that land on printed cDNA will get 
transfected and each spot corresponding to the printed cDNA will have a cluster of 30 to 
80 cells expressing a gene of interest as the cells divide. The resulting living cell arrays 
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contain the transfected cells with in a background of untransfected cells. The function of 
genes such as apoptosis, cell adhesion, and signal transduction can be identified using 
transfected cell arrays (Ziauddin & Sabatini 2001; Wu et al. 2002). Furthermore, 
transfected cell microarrays can also be used to monitor the presence of biological agents 
and toxicants (Delehanty et al. 2004). Eukaryotic cell microarrays were developed by 
printing whole intact cells on poly-L-lysine coated glass slides, and the arrays were used 
of characterize cell surface-specific antibodies (Schwenk et al. 2002).  
 
Further, the development of tissue microarrays helps in high throughput in situ 
analysis of specific molecular targets in a large number of tissue specimens (Kononen et 
al. 1998). Tissue microarrays are constructed from needle biopsies taken from paraffin 
embedded tissue specimens. These biopsies are then embedded into a master paraffin-
block. The master block containing tissue specimens is sectioned into slices and 
transferred onto slides. Tissue microarrays can be probed for molecular targets such as 
proteins, DNA or RNA employing immunohistochemistry, fluorescence in situ 
hybridization, or other detection methods (Kallioniemi et al. 2001).  
 
Antibodies immobilized on a microarray substrate constitute antibody arrays. 
Antibody arrays have been employed for the study of relative abundance of proteins in 
diseased versus normal tissues (Haab et al. 2001). Antibody arrays were used to study 
cancer markers (Miller et al. 2003) and to profile proteins in cancer tissues (Knezevic et 
al. 2001; Miller et al. 2003). Antibodies targeting the surface markers of cells have been 
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used on a microarray to classify leukemias.  Sandwich antibody microarrays have been 
used to measure cytokines and chemokines (Schweitzer et al. 2002). A microarray 
immunoassay has been described for simultaneous detection of bacteria and proteins. 
Antibodies immobilized on slides were used to capture analytes under flow conditions 
and the captured analytes were detected with labeled antibodies.  Assays could be 
completed with in 15 minutes. The detection limits for cholera toxin, staphylococcus 
enterotoxin B, ricin, and Bacillus globigii whole cells were 8 ng per ml, 4 ng per ml, 10 
ng per ml, and 6.2x104 CFU per ml respectively (Delehanty & Ligler 2002).  
 
In addition, antigen arrays have been developed for the detection and 
characterization of antibodies. Antibodies against infectious agents such as Toxoplasma 
gondii, rubella virus, cytomegalovirus and herpes simplex virus types 1 and 2 have been 
detected in human serum using antigen arrays (Mezzasoma et al. 2002; Bacarese-
Hamilton et al. 2004). Autoantigen microarrays were developed for the characterization 
of autoantibody responses and to define autoantigens in human autoimmune diseases 
(Joos et al. 2000; Robinson et al. 2002). A protein microarray chip was developed for the 
serologic diagnosis of hepatitis virus C infection (Yuk et al. 2004).  
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Figure 1. Systematic Evolution of Ligands by EXponential enrichment (SELEX). 
The process of in vitro selection of aptamers involves the incubation of a target of interest 
with a random single stranded oligonucleotide library. After incubation, the sequences 
that do not interact with the target will be partitioned from those that interact. The 
sequences that bind the target will be eluted and amplified for use in the next of selection. 
The selected pool is tested for enrichment of sequences that bind the target after a few 
rounds of selection. The enriched pool is cloned and sequenced. Individual selected 
sequences are further characterized for binding specificity and affinity (See text for 
details).  
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Figure 2. Schematic diagram of bacterial lipopolysaccharide structure. LPS is an 
amphipathic molecule and consists of three regions – a hydrophobic lipid-A, hydrophilic 
core oligosaccharide and an outer polysaccharide O-antigen. 
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CHAPTER III 
 
 
In vitro selection of a DNA aptamer against Francisella tularensis O-
polysaccharide 
 
Abstract 
 
Francisella tularensis, a Gram-negative, facultative intracellular bacterium is the 
etiological agent of the disease tularemia. The pathogen is highly infectious with a 
reported infective dose of ten organisms for humans. Tularemia is endemic in many parts 
of the world. Francisella tularensis is considered to be a potential 
biowarfare/bioterrorism agent owing to its high infectivity and ease of spread after 
aerosolization. Presently, the identification of the organism or the diagnosis of tularemia 
is mainly done by antibody-based assays. Special techniques such as antigen detection 
assays and PCR are limited to reference and research laboratories. Systematic Evolution 
of Ligands by Exponential Enrichment (SELEX), an in vitro technique, offers an 
alternative and novel tool known as aptamer for diagnostic and biosensor applications. In 
the present study, we adopted SELEX for in vitro selection of specific ssDNA ligands to 
F. tularensis subspecies tularensis O-antigen.  The selected DNA aptamer Ft1 was found 
to bind specifically to LPS from F. tularensis subspecies tularensis and subspecies 
holarctica. This is not unexpected as antibodies raised against LPS of F. tularensis LVS 
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(Live Vaccine Strain derived from subspecies holarctica) recognized both subspecies 
tularensis and subspecies holarctica. Furthermore, aptamer Ft1 differentiated F. 
tularensis subspecies tularensis and subspecies holarctica from F. philomiragia, 
Escherichia coli, Pseudomonas aeruginosa, Shigella flexneri, Vibrio cholerae, 
Salmonella typhimurium, Yersinia species and Brucella ovis. However, aptamer Ft1 did 
not recognize whole F. tularensis cells in binding assays. This could be due to 
recognition of the core oligosaccharide part of LPS by the aptamer and the core 
oligosaccharide may not be readily accessible on the surface of bacterium. The use of 
whole bacterial cells instead of purified O-polysaccharide containing core 
oligosaccharide as target may help in selecting aptamers against a surface target of the 
bacteria.  
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Introduction 
 
Francisella tularensis, the causative agent of the disease tularemia, is a Gram-
negative, facultative intracellular bacterium, and the pathogen is one of the most 
infectious bacteria known. Tularemia is a disease of rodents, lagomorphs and humans and 
the disease is widely endemic in North America, Europe and Asia. 
 
Francisella tularensis is one of the two recognized species of the genus 
Francisella within the family Francisellaceae, the other species being F. philomiragia 
(Ellis et al. 2002). Francisella philomiragia is an opportunistic pathogen causing disease 
in immunocompromised individuals and is often associated with water (Titball et al. 
2003). Francisella philomiragia shares more than 98% 16S rRNA sequence homology 
with F. tularensis (Forsman et al. 1994).  The strains of F. tularensis are grouped into 
one of four subspecies: tularensis (type A), holarctica (type B), mediasiatica and 
novicida.  (Ellis et al. 2002; Titball et al. 2003). Although all the subspecies of F. 
tularensis are genetically and antigenically similar, they differ in virulence and 
geographical distribution. Strains of F. tularensis subspecies tularensis are highly 
virulent for humans and are generally reported from North America, but recently also 
from Europe (Ellis et al. 2002). The infective dose required is very small with as little as 
ten bacteria reported to cause human infection (Ellis et al. 2002). The mortality 
associated with F. tularensis subspecies tularensis was reported to be 5-30% prior to the 
advent of antibiotics (Titball et al. 2003). Human infections caused by strains of 
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subspecies holarctica and mediasiatica are less severe with low mortality (Titball et al. 
2003). Strains of F. tularensis subspecies novicida are less virulent, with infection most 
often seen in immunocompromised individuals (Titball et al. 2003).   
 
Francisella tularensis is considered to be a potential biological weapon owing to 
its ability to spread rapidly upon aerosolization and a very low infective dose (Dennis et 
al. 2001). The organism is very hardy and can persist in watercourses and at low 
environmental temperatures making it an ideal agent of bioterrorism. Aerosol 
dissemination of F. tularensis in a populated area would be expected to cause a large 
number of acute cases 3 to 5 days after the exposure, with overwhelming medical and 
public health consequences (Dennis et al. 2001).  
 
Clinical cases of tularemia are generally diagnosed by antibody-based tests such 
as agglutination test or ELISA. However, at least two weeks are required for 
development of antibodies in humans after infection (Koskela & Salminen 1985), and 
antibodies developed against certain strains of F. tularensis have failed to agglutinate 
commercially available antigens (Clarridge, III et al. 1996). Moreover, ELISA 
procedures are time consuming, involving blocking, several steps of incubations, and 
washings.  F. tularensis is a fastidious organism which grows slowly at 37° C and 
requires special growth conditions (Doern 2000). Culturing of the organism in the 
laboratory is a potential source of infection to laboratory personnel (Burke 1977), making 
it a less acceptable method for diagnosis and identification. Special techniques for the 
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identification of Francisella such as antigen detection assays, PCR, ELISA, 
immunoblotting and pulsed-field gel electrophoresis are generally performed in reference 
and research laboratories (Dennis et al. 2001).  In the event of the use of F. tularensis as 
a biological weapon, rapid detection of organisms in environmental samples becomes 
crucial to containment and clean-up efforts. Additionally, a simple, rapid and reliable 
diagnostic test is needed to screen persons exposed to the pathogen. 
 
Systematic Evolution of Ligands by Exponential Enrichment (SELEX) offers an 
alternative and novel tool, known as aptamer, for diagnostic and biosensor applications 
(Brody et al. 1999; Hesselberth et al. 2000; O'Sullivan 2002).  Aptamers are 
oligonucleotides (RNA, DNA or modified nucleotides), that are selected in vitro through 
SELEX for specific binding to a variety of targets, ranging from simple ions to whole 
cells (Ellington & Szostak 1990; Tuerk & Gold 1990; Ellington & Szostak 1992; 
Famulok & Mayer 1999; Wilson & Szostak 1999). Aptamers have several advantages 
over antibodies (Jayasena 1999; O'Sullivan 2002). Although, aptamers are described as 
“emerging molecules that rival antibodies in diagnostics” (Jayasena 1999), so far, the 
selected aptamers have found very few applications in diagnostic assays and continue to 
be mainly the subject of academic interest (Hesselberth et al. 2000).  A DNA aptamer 
based magnetic bead-electrochemiluminescence assay has been developed for the 
detection of anthrax spores (Bruno & Kiel 1999). The present study involves the selection 
of aptamers to O-antigen of F.  tularensis subspecies tularensis. We selected an aptamer, 
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Ft1, which specifically recognized LPS of F.  tularensis subsp. tularensis and subsp. 
holarctica. The aptamer Ft1 could differentiate F. tularensis lipopolysaccharide (LPS) 
from other closely related Gram-negative bacterial LPS.  
 
Materials and Methods  
 
Bacteria and lipopolysaccharide  
 
Francisella tularensis subspecies tularensis strain OSU 10 (feline isolate), F. 
tularensis subspecies holarctica strain 3093 (beaver isolate) and Brucella ovis – 1 (sheep 
isolate) are field isolates from our strain collection. Yersinia enterocolitica-1 and Yersinia 
pseudotuberculosis-1 are field isolates from animals, kindly provided by the Oklahoma 
Animal Disease Diagnostic Laboratory. Yersinia pestis D-1 (avirulent mutant) was kindly 
supplied by Dr. Robert Brubaker, Michigan State University. Salmonella typhimurium 
14028 and Francisella philomiragia 25105 were obtained from American Type Culture 
Collection (Manassas, VA). Lipopolysaccharide (LPS) from these bacteria were isolated 
using Tri-reagent method described previously (Yi & Hackett 2000). LPS preparations 
from Escherichia coli O111:B4, Pseudomonas aeruginosa serotype 10, Vibrio cholera 
Inaba 569B and Shigella flexneri serotype 1A were purchased from Sigma (St. Louis, 
MO).  
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Isolation of F. tularensis subspecies tularensis O-antigen  
 
 The O-antigen from F. tularensis subspecies tularensis was isolated from LPS by 
acid hydrolysis. The LPS was suspended in 1% acetic acid and heated at 100° C for 2.5 
hours. The lipid portion was then removed by centrifugation at 12000g for 20 minutes, 
and the supernatant containing O-antigen was freeze dried. The O-antigen was further 
purified by gel filtration chromatography. The lyophilized O-antigen was suspended in 
50mM ammonium acetate and passed through Toyopearl HW-50F (Supelco, Bellefonte, 
PA) gel filtration column. Elution of polysaccharide was monitored by refractive index. 
The three major fractions were pooled separately and freeze dried. The O-antigen 
fraction, eluting just after the void volume, was identified by its immunoreactivity with 
monoclonal antibodies (BioDesign, Saco, ME) specific for F. tularensis O-antigen and by 
its 1H NMR spectrum.  
 
SELEX Procedure 
 
SELEX DNA library: Synthetic template DNA containing 30 randomized 
nucleotides flanked by fixed sequences for PCR amplification was used in the study 
(Integrated DNA Technologies, Coralville, IA). The sequence of DNA library was 5’-
TTGAGCGTTTATTCTGAGCT CCC- (N) 30 – TTCGACATGAGGCCCGGATC – 3’ 
and the primers used were 5’-TT GAGCGTTTATTCTGAGCTCCC -3’ and 5’ – *B- 
GATCCGGGCCTCATGTCGAA – 3’ (*B = biotin).  
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Polymerase Chain Reaction and generation of ssDNA: All reaction 
mixtures for PCR contained 1 µM each primer, 3 mM MgCl2, 200 µM dNTPs, GeneAmp 
1X PCR gold buffer (15 mM Tris-HCl, pH 8.0, 50 mM KCl) and AmpliTaq Gold DNA 
polymerase (1.5 units/ 50 µl; Applied Biosystems, Foster City, CA). Amplifications were 
carried out in a MJ Research, Inc. thermal cycler (Waltham, MA) at 94 ° C for 5 minutes 
preheating followed by 20 cycles of 94° C for 30 sec, 55° C for 30 sec and 72° C of 1 
minute. The PCR product was gel purified using Nusieve GTG agarose (BioWhittaker 
Molecular Applications, Rockland, ME). ssDNA was generated by using  the 
Streptavidin MagneSphere paramagnetic particles (Promega, Madison, WI). The gel 
purified dsDNA (with 5’ biotinylated negative sense strand) was incubated with 
streptavidin-paramagnetic particles in 0.5X SSC buffer for 10 minutes and then washed 
with 0.1X SSC buffer to remove unbound dsDNA. The bound dsDNA was denatured by 
incubation with 0.2 N NaOH for 5 minutes. Then the streptavidin-paramagnetic particles 
were captured on a magnetic stand and the solution containing ssDNA was transferred to 
a new microcentrifuge tube and the ssDNA was desalted by ethanol precipitation.  
 
Selection procedure: Francisella tularensis subspecies tularensis O-antigen 
was immobilized on a circular disc of nitrocellulose membrane (~ 0.5 cm2, 0.45µM, Bio-
Rad laboratories, Hercules, CA) by overnight incubation with 10 mg/ml O-antigen in 
SELEX binding buffer (20mM Tris, pH 7.5 / 100 mM NaCl / 5 mM MgCl2). The 
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immobilized O-antigen was then incubated with ssDNA library in binding buffer at room 
temperature. After incubation the membrane was washed with binding buffer to remove 
unbound ssDNA.  The bound ssDNA was eluted by heating the membrane in 7 M urea at 
94 ° C for 10 minutes. ssDNA - O-antigen binding was performed under progressively 
increasing stringency. The duration of incubation was decreased from 1 hour for initial 
rounds (1 – 5) of selection to 30 minutes for the closing rounds (6 -10) and similarly, the 
number of washings was increased from 3 times to 5 times (10 minutes each). The eluted 
ssDNA was ethanol precipitated and amplified by PCR for the next round of selection. 
For the first round of selection 10 µg of synthetic ssDNA from the library (~2.7x1014 
molecules) was used for selection. Counter selections were made against 
lipopolysaccharides from Escherichia coli serotype 0111:B4, Pseudomonas aeruoginosa 
serotype 10, Shigella flexneri serotype 1A and whole cells of Salmonella typhimurium 
ATCC14028 prior to the 4th, 5th, 6th and 7th rounds of selection, respectively, using 
conditions described above.   
 
 The enriched DNA library from the 10th round of SELEX was PCR amplified and 
cloned into the plasmid vector pCRII-TOPO and chemically transformed into competent 
TOP10 E. coli cells (TOPO TA Cloning, Invitrogen, Carlsbad, CA). Clones were 
selected, plasmid DNA isolated by the alkaline lysis, and sequences of seventy clones 
determined by standard dideoxy terminator method (Recombinant DNA Core facility, 
Oklahoma State University). The sequences obtained were arranged into different groups 
by constructing a dendrogram using SeqWeb software version 2.1 (Accelrys, Inc. San 
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Diego, CA), and sequences within a group were aligned using AlignX (Vector NTI Suite, 
v.6, Informax, Bethesda, MD).  
 
Dot-blot assay  
 
Lipopolysaccharides were blotted on to nitrocellulose membranes and the 
membranes were blocked with 5% non-fat milk in SELEX binding buffer overnight at 
4°C. After incubation the membranes were washed in binding buffer for 5 minutes, then 
incubated with 33P-labeled individual aptamer sequences (~ 5 pmoles) in binding buffer 
at RT for 30 minutes. DNA was labeled with 33P using [γ-33P] ATP and T4 
polynucleotide kinase (DNA 5´ End-Labeling System, Promega, Madison, WI) and 
unincorporated [γ-33P] ATPs were removed by size exclusion chromatography using 
Sephadex G-25 Quick Spin column (Roche diagnostics corp., Indianapolis, IN). Ten-fold 
molar excess of BSA and 100-fold molar excess of tRNA were included in binding 
reactions as competitors to avoid non-specific binding. The membranes were washed in 
binding buffer four times (10 minutes each), air dried and subjected to autoradiography.   
 
Microtiter plate based binding assays  
 
96-well microtiter plates (Immulon 1B, Dynex Technologies, Chantilly, VA) were 
coated with solutions of LPS (0.5 µg/µl, 200µl per well) in SELEX binding buffer at 37° 
C for 3h followed by overnight incubation at 4° C. The LPS solution was aspirated and 
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wells were blocked with 1% BSA in binding buffer at RT for 1h. Wells were then washed 
in binding buffer for 5 minutes and incubated with 33P-labeled individual aptamer 
sequences (0.8 – 1.2 pmoles/well) at RT for 30 minutes. DNA was labeled with 33P as 
described above. The binding reactions included 10-fold and 100- fold molar excess of 
BSA and tRNA, respectively. After incubation the wells were washed (3X 10 min) with 
binding buffer. The amount of radioactivity retained in each well was determined by 
liquid scintillation analysis.  
 
 
Results  
 
 
Characterization of Francisella tularensis subspecies tularensis LPS and 
O-antigen  
 
 Isolated Francisella tularensis subsp. tularensis LPS was analyzed by SDS-
PAGE and western blotting. The LPS sample was run on 12.5% acrylamide gels and 
stained with silver stain. The LPS showed the characteristic ladder pattern on acrylamide 
gels indicating variation in the polysaccharide side chain length (data not shown). 
Further, the LPS immunoreacted with monoclonal antibodies (BioDesign, Saco, ME) 
specific for F. tularensis LPS (data not shown).  
 
Selection of DNA aptamers to Francisella tularensis subspecies 
tularensis O-antigen  
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 The ssDNA sequences that bind to Francisella tularensis O-antigen were selected 
by established SELEX protocols (Ellington & Szostak 1990; Tuerk & Gold 1990; 
Ellington & Szostak 1992) with some modifications. The DNA library had 30 
randomized bases flanked by fixed sequences for PCR amplification. The starting pool 
was diverse with approximately 1014 individual sequences. Nitrocellulose membrane 
discs were used as a matrix to immobilize O-antigen for separation of unbound sequences 
from bound sequences. 
 
 Sequencing of 70 clones from the selected aptamer pool resulted in 24 individual 
sequences (Table 1). The high sequence redundancy of the selected pool indicates the 
completion or nearing completion of SELEX process with the selection of high affinity 
and specific aptamers. The length of the randomized region varied from 28 nucleotides to 
30 nucleotides, although the starting pool had 30 nucleotides in the randomized region. 
This is most likely due to insertion and deletion of nucleotides by DNA polymerase 
during amplification (Yang et al. 1998). The selected sequences were rich in guanine 
content and guanine percentage varied from 10 to 67 percent (Table 1).  
 
 The selected sequences could be grouped into different families of aptamers based 
on sequence homology, with the majority of sequences (57%) falling into one family 
(Figure 1; Table 1).   Ft1 appeared 31 times (44%) and also showed high sequence 
homology with 5 other selected sequences (Table 1). This prompted us to reason that the 
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randomized region of aptamer Ft1 could be the motif required for binding (5’-
AGGGCGGGAGTGGGTGTGGAAGGTGCGG-3’; aptamer Ft1). 
 
Specific identification of Francisella tularensis LPS by aptamer Ft1 
 
 Aptamer Ft1 along with other full length selected aptamers (with flanking fixed 
sequences) Ft1, Ft5, Ft23, Ft37 and Ft79 were tested for their specific binding to 
Francisella tularensis LPS and for the ability to differentiate other closely related Gram-
negative bacterial LPS. Among the sequences tested aptamer Ft1 showed high specific 
binding to F. tularensis LPS compared to other sequences tested. Autoradiograph results 
of the dot-blot assay showed intense binding of aptamer Ft1 to F. tularensis LPS (Figure 
2). The starting pool showed a faint binding to F. tularensis LPS. Further, aptamer Ft1 
specifically bound F. tularensis LPS in a concentration dependent manner but not E. coli 
LPS immobilized on the same membrane (Figure 3).  
 
 Binding of aptamer Ft1 to Francisella tularensis LPS was tested in microtiter 
plate-based assays.  Aptamer Ft1 showed higher binding to F. tularensis subsp. tularensis 
LPS compared to either the starting pool or an arbitrary control sequence of 28 
nucleotides (Figure 4). Further, Ft1 bound strongly to both F. tularensis subspecies 
tularensis (type A) and subspecies holarctica (type B; Figure 5).  However, the aptamer 
showed only moderate binding to F. philomiragia, the other species of genus Francisella 
(Figure 5).  Further, aptamer Ft1 differentiated F. tularensis LPS from other Gram-
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negative bacterial LPS (Figure 4 and 5). Aptamer Ft1 did not bind to LPS from E. coli, 
Pseudomonas aeruginosa, Shigella flexneri, Vibrio cholerae, Salmonella typhimurium, 
Yersinia species and Brucella ovis.  These results indicate the specificity of aptamer Ft1 
to F. tularensis subsp. tularensis and subsp. holarctica.  
 
Discussion 
 
 Francisella tularensis has been considered a threat as a possible biological 
weapon and has acquired new importance with the recent acts of terrorism across the 
globe. In addition, the pathogen continues to be responsible for human infections in many 
countries. Presently the identification of the organism or the diagnosis of tularemia is 
based on isolation of the causative agent, immunoassays, and PCR. In the present study 
we have selected DNA aptamers against the O-antigen of Francisella tularensis 
subspecies tularensis (Strain OSU 10). High affinity and high specificity aptamers have 
been selected against a variety of targets (Famulok & Mayer 1999; Wilson & Szostak 
1999). In the majority of these studies the target for aptamers is protein. A few studies 
have shown the feasibility of selecting DNA and RNA aptamers to carbohydrates or 
polysaccharides. Aptamers have been selected against cellobiose (Yang et al. 1998), 
sephadex (Srisawat et al. 2001), chitin (Fukusaki et al. 2000) and aminoglycosides 
(Wilson & Szostak 1999).  
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 The identification of gram-negative bacteria is traditionally done by serotyping 
using antibodies specific for O-antigen. Monoclonal antibodies specific to LPS have been 
used for identification of F. tularensis (Greiser-Wilke et al. 1989; Fulop et al. 1991; 
Grunow et al. 2000). Targeting of O-antigen for identification of Gram-negative bacteria 
offers several advantages over other targets such as rRNA, or specific genomic 
sequences. In the present study, F. tularensis O-antigen was used as target for aptamer 
selection for several reasons: (i) O-antigen provides specificity and is present in high 
copy number on the cell surface (ii) repeating tetra-saccharide subunits of O-antigen are 
likely to present multiple targets per molecule, and (iii) O-antigen is expected to be 
relatively stable during transport of clinical samples or in the environment.  LPS 
preparations from F. tularensis and F. novicida were found to exhibit species-specific 
and genus-specific epitopes (Pavlovich et al. 2000) and these antigenic determinants of F. 
tularensis LPS were found to be localized on O-polysaccharide and not on the core 
region (Pavlovich et al. 2000). Identification of bacteria based on genomic DNA or 
rRNA requires lyzing of cells to release the targets and invariably the nucleic acid target 
has to be amplified to be highly sensitive. The nucleic acid target also poses the problem 
of secondary structure interfering with probe binding and is susceptible to nucleases.   
 
 The use of purified O-antigen instead of LPS as the target was intended to avoid 
selection of aptamers to the lipid-A portion, which is highly conserved among Gram-
negative bacteria and also not readily accessible on the surface.  In vitro selection of 
aptamers to a purified single target requires a partitioning matrix or immobilization of the 
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target to separate the unbound sequences during selection. Adsorption and 
immobilization of F. tularensis O-antigen onto nitrocellulose membrane was tested using 
monoclonal antibodies specific for F. tularensis O-antigen. In addition, high 
concentrations (10 mg/ml) of the polysaccharide were used to ensure saturation of 
binding sites on the membrane. It has been shown that microbial polysaccharides can be 
immobilized on glass slides coated with nitrocellulose without chemical conjugation, and 
that such immobilized polysaccharides retain their immunological properties to be 
recognized by specific antibodies (Wang 2003). We also adopted counter selection in 
order to achieve selection of highly specific ligands, and to hasten the selection process. 
LPS preparations from related bacteria and whole cells were used for the counter 
selection. Negative selection and counter selection are employed along with alteration of 
incubation time for the efficient enrichment of the aptamer library during SELEX process 
(O'Sullivan 2002). 
 
 The selected aptamers are characterized by high sequence redundancy and high 
guanine content (Table 1). DNA aptamers selected against cellobiose and chitin were also 
rich in guanine (Yang et al. 1998; Fukusaki et al. 2000). This suggests that guanine 
residues might contribute to the recognition of polysaccharide/carbohydrate targets. 
Aptamer Ft1 showed strong binding to F. tularensis LPS immobilized on nitrocellulose 
membrane compared to the starting pool, indicating the selection of the aptamer Ft1 
against the F. tularensis O-antigen (Figure 2). The binding of aptamer Ft1 to F. tularensis 
LPS but not to E. coli LPS immobilized on the same membrane in a concentration 
  65 
 
dependent manner establishes the specificity (Figure 3). Further specific recognition of F. 
tularensis LPS immobilized on the polystyrene surface (microtiter plate) by the aptamer 
Ft1 suggests its selection against the O-antigen of F. tularensis. The binding of starting 
pool is comparable to that of control sequence (Figure 4). The adsorption of LPS 
molecules on polystyrene surfaces seems to occur through hydrophobic interactions 
involving lipid-A, resulting in the orientation of LPS molecules on polystyrene surface 
similar to that on bacterial surface (Peula-Garcia et al. 2002). This makes the microtiter 
plate-based assays more appropriate for evaluating ligands to LPS molecules.   The 
aptamer Ft1 recognized both F. tularensis subspecies tularensis (type A) and subspecies 
holarctica (type B) and differentiated the only other species, F. philomiragia (Figure 5). 
This is not surprising as the monoclonal antibodies raised against LPS of F. tularensis 
LVS (ATCC 29684) recognized subspecies tularensis and subsp. holarctica suggesting a 
structural similarity of LPS between the two subspecies (Grunow et al. 2000). The 
moderate binding of aptamer Ft1 to F. philomiragia suggests a possible close structural 
relatedness of O-antigen between the two species. It would be interesting to test the 
binding of aptamer Ft1 to F. tularensis subsp. novicida and mediasiatica along with other 
isolates. In addition, the aptamer differentiated F. tularensis from E. coli, Pseudomonas 
aeruginosa, Shigella flexneri, Vibrio cholerae, Salmonella typhimurium, Yersinia species 
and Brucella ovis (Figure 5). These Gram-negative bacteria are possibly related to F. 
tularensis (Grunow et al. 2000). Brucella species, Haemophilus influenza and Yersinia 
pestis serologically cross react with F. tularensis due to presence of common protein 
antigens (Greiser-Wilke et al. 1989). The structure of F. tularensis subspecies holarctica 
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O-antigen is related to those of Pseudomonas aeruginosa O6, immunotype1 and II D 
1008, and Shigella dysenteriae type 7 (Vinogradov et al. 1991). The tetrasaccharide 
subunits of O-antigens from these bacteria differ in one constituent monosaccharide 
(Vinogradov et al. 1991). The serological relationship of these two species with F. 
tularensis is not established.  
 
Although the selected aptamer Ft1 was found to recognize LPS of F. tularensis 
subspecies tularensis and subspecies holarctica immobilized on either nitrocellulose 
membrane and on polystyrene surface (microtiter plates), the aptamer did not bind to 
whole F. tularensis cells. Fluorophore labeled aptamer Ft1 did not show significant 
binding to whole F. tularensis cells when analyzed by flow cytometry and confocal 
microscopy (data not shown). This could be due to recognition of the core polysaccharide 
part of LPS by the selected aptamer, and the core polysaccharide may not be readily 
accessible for the aptamer to bind. Mild acid hydrolysis of LPS cleaves the ketosidic 
bond that links the core polysaccharide with lipid-A. Therefore purified O-polysaccharide 
does retain core polysaccharide. Alternatively, use of whole bacterial cells in selection 
process may facilitate selection of aptamers against the surface targets of bacteria.  
 
Aptamers are versatile molecules that have the potential to overcome limitations 
associated with use of antibodies in diagnostic assays (Jayasena 1999; O'Sullivan 2002). 
Aptamers can be rapidly selected against a wide range of targets by an in vitro process,  
and it is possible to select aptamers of desired properties. Aptamers are also very stable 
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and reporter molecules can be easily attached. Although, considerable progress has been 
made on the therapeutic applications of aptamers with many aptamers in clinical trials, 
their potential use as diagnostics has yet to be realized. 
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Figure 1. Selected sequence alignment dendrogram. DNA sequences selected against 
the O-antigen of Francisella tularensis subspecies tularensis (strain OSU 10) were 
grouped into different families based on randomized region sequence homology using 
SeqWeb software version 2.1 (Accelrys, Inc. San Diego, CA). 
  69 
 
 
 
 
 
  70 
 
 
 
 
 
Table 1. Sequences of DNA aptamers selected against the O-antigen of F. tularensis 
subsp. tularensis (strain OSU 10). Only the randomized regions of the selected 
sequences are shown along with the number of times sequences appeared (out of 70 
clones sequenced) and guanine content. The selected sequences were classified into 
different groups based on sequence homology. The sequences showed high sequence 
redundancy with the majority of sequences falling into one group and are rich in guanine.    
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Aptamer  # Clones  Randomized Region   Guanine % 
 
Ft1   (31)  –AGGGCGGGAGTGGGTGTGGAAGGTGCGG  64 
Ft56      (1)  CAGGGCGGGAGTGGGTGTGGAAGGTGCGG  62 
Ft29      (2)  -AGGGCGGGAGTGGGTGTGGAAGGTGTGG  64 
Ft38      (1)  -AGGGCAGGAGTGGGTGTGGAAGGTGCGG  60 
Ft4      (4)   -GGGGCGGGAGTGGGTGTGGAAGGTGCGG  67 
Ft64   (1)  -AGGGCGGAAGTGGGTGTGGAAGGTGTGG  60 
     
Ft79      (1)  GCGGCACCGAAGTGGGTGTGGAAGGTGTGC  50 
Ft82      (1) GCGGCACCGAAGTGGGTGTGGAAGGTGTGG  51 
     
Ft23      (4)  GGGGTCCGGGGGGGTCCTAAACGAGGGGTG 56 
Ft70      (1)  TGGGTCCGGGGGGGTCCTAAACGAGGGGTG  53 
 
Ft12      (1)  ACGAGCACAGTCATCACATTACCACCCCGG  16 
Ft73      (1) CTGAGCGCAGTC – TGTATTTCCCAACCCTG  20 
 
Ft37      (2)  CGAGCGCAGTCC- - ACCATCTCGTCTACCGG  24 
Ft46      (1)  CGAGCACAGTCCTTATCACTTACTCGCCCG-  16 
      
Ft43      (1)  ACGGCAGC-ACAGTACCACCTACCAC-CCCG- 17 
Ft68      (1)  -  -ACCATCTACCCTACTACCTACCTCGCCCGG 10 
 
Ft18      (1)  -  -  -TGAGCACATTCACATTCATCTCTCTCCCGG 13 
Ft32      (2)  ATGAGCGCACT- ACATTTACACCA-TCTCCG-- 13 
 
Ft51      (1) -  -  CATCACCTCGTACATT- CTCGCTTTACCGCC 10 
Ft59      (2)   AGCATGGGGGC-TACATCACTATCTTCACCG-- 23 
 
Ft5        (6) - -  GGCCGATGAACGATAGGATGGCTAGGGGGG- 50 
Ft15      (2)  GGTGCTGGTGAAG - GTAG - - TTGTTAGGGGTCC 46 
 
Ft14  (1) TGCGCAGACTGTTCTTCCTTATCTACCCGG  20 
Ft55  (1) GGCAGATGTCCATGGGTGTGGAAGGTGCGG  50 
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Figure 2. Binding of aptamer Ft1 to F. tularensis LPS immobilized on nitrocellulose 
membrane. Binding assay was performed with 33P radiolabeled starting pool (SP) and 
aptamer Ft1. The labeled oligonuclotides (~ 5 pmoles) were incubated with F. tularensis 
subsp. tularensis LPS (30 and 50 µg) immobilized on nitrocellulose membrane. 
Autoradiograph was developed after washing off unbound ssDNA. The aptamer Ft1 
showed intense binding to F. tularensis LPS, whereas the starting pool showed faint 
binding.  
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Figure 3. Specific binding of aptamer Ft1 to F. tularensis LPS immobilized on 
nitrocellulose membrane in a concentration dependent manner. Different amounts of 
F. tularensis subsp. tularensis LPS and E. coli O111:B4 LPS in (25 µg to 0.1953 µg) 
were blotted on a nitrocellulose membrane. The membrane was blocked with non-fat 
milk and then incubated with with 33P radiolabeled aptamer Ft1. Autoradiograph was 
developed after washing off unbound ssDNA. The aptamer Ft1 shows concentration 
dependent specific binding to F. tularensis LPS but not to control E. coli LPS blotted on 
the same membrane.  
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Figure 4. Specific binding of aptamer Ft1 to F. tularensis LPS adsorbed onto 
polystyrene surface of a microtiter plate. Binding of aptamer Ft1 to F. tularensis 
subsp. tularensis LPS, E. coli O111:B4 LPS and Pseudomonas aeruginosa serotype 10 
LPS was compared with the starting pool and an arbitrary control sequence of 28 
nucleotides. 33P radiolabled ssDNA was incubated with LPS adsorbed onto the 
polystyrene surface of a microtitre plate.  After washings to remove unbound DNA, the 
radioactivity retained was determined by scintillation counting. The aptamer Ft1 
specifically binds to F. tularensis LPS but not to E. coli and P. aeruginosa LPS. Binding 
of the starting pool is comparable to that of the control sequence.  Each bar represents the 
average CPM ± standard error of three independent experiments with duplicates (n = 6).  
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Figure 5. Specificity of the aptamer Ft1 to Francisella tularensis species. Aptamer Ft1 
showed strong binding to F. tularensis subsp. tularensis and subsp. holarctica in 
microtiter plate binding assays. The aptamer exhibits a moderate binding to F. 
philomiragia LPS suggestive of a possible close structural relatedness of O-antigen 
between the two species. The aptamer did not cross-react with other possibly related 
Gram-negative bacteria. Each value represents the average CPM ± standard error of three 
independent experiments with duplicates (n = 6).  
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CHAPTER IV 
 
 
 
Structural analysis of the O-antigen of Francisella tularensis subspecies 
tularensis strain OSU 10 
 
 
Francisella tularensis, the causative agent of the disease tularemia, is one of the 
most infectious bacteria known. F. tularensis subspecies tularensis (type A) and 
holarctica (type B) are the major subspecies, with the former being highly virulent for 
humans (Conlan et al. 2002).  A live vaccine strain (LVS) of F. tularensis empirically 
derived from a virulent strain of type B F. tularensis provides considerable protection 
against highly virulent type A strains in humans (Fulop et al. 2001; Conlan et al. 2002). 
Although F. tularensis LVS is attenuated for humans, it is fully virulent for mice (Conlan 
et al. 2002), and infection with F. tularensis LVS in mice has been used as an 
experimental model of tularemia in a number of studies.  
 
Immunization of mice with lipopolysaccharide (LPS) derived from F. tularensis 
LVS induced protection against intraperitoneal challenge with the live vaccine strain but 
not against a virulent strain of type A F. tularensis. However, the immunization 
significantly increased the survival time in mice challenged with the virulent strain of 
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type A F. tularensis (Fulop et al. 2001). Similarly, mice vaccinated with O-antigen of the 
LPS from F. tularensis LVS chemically conjugated to bovine serum albumin were 
protected against an intradermal challenge with a highly virulent strain of type B F. 
tularensis but not against a virulent type A strain (Conlan et al. 2002). Monoclonal 
antibodies directed against O-antigen and core polysaccharide of the LPS from F. 
tularensis LVS recognized both type A and type B strains (Fulop et al. 1991). This 
suggests the presence of common epitopes in the LPS of both subspecies. However, the 
mouse protection studies suggest possible differences in the structure of LPS/O-antigens 
between the two subspecies (Fulop et al. 2001; Conlan et al. 2002; Prior et al. 2003). 
Conversely, different mechanisms of protection may be required to resolve infections 
caused by the two subspecies (Fulop et al. 2001).   
 
The O-antigen structure of F. tularensis strain 15 (a vaccine strain derived from 
type B F. tularensis in the former Soviet Union) was determined to contain repeating 
tetra-saccharide subunits:  4-(α-D-GalpNAcAN-(1-4)- α-D-GalpNAcAN-(1-3)- β-D-
QuipNAc-(1-2)-β -D-Quip4NFo-1), using 1H- and 13C-NMR spectroscopy (Vinogradov 
et al. 1991). Francisella tularensis LVS was also found to express O-antigen identical to 
that of F. tularensis strain 15 (Conlan et al. 2002). Studies on the structure of O-antigen 
from virulent strains of type A F. tularensis have been limited to the Schu S4 strain 
which is a virulent but highly passaged laboratory strain (Prior et al. 2003). The repeating 
units of the O-antigens from Schu S4 strain and LVS were presumed to be the same 
based on MALDI-MS analysis (Prior et al. 2003). In the present study we report the 1H- 
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and 13C-NMR spectroscopy structural analysis of O-antigen from a field strain of type A 
F. tularensis (strain OSU 10).  
 
Francisella  tularensis subsp. tularensis (strain OSU 10) was isolated from a cat 
that died of tularemia and subspecies identification was based on BIOLOG metabolic 
fingerprinting (Biolog) and PCR (Petersen et al. 2004) and confirmed by Centers for 
Disease Control and Prevention (Atlanta, GA, USA). Lipopolysaccharide from strain 
OSU 10 was isolated using the Tri-reagent method described previously (Yi & Hackett 
2000) and analyzed by SDS-PAGE and western blotting. LPS samples were run on 12 % 
acrylamide gels followed by silver staining. Isolated LPS showed the characteristic ladder 
pattern on acrylamide gels indicating variation in the polysaccharide side chain length 
(Fig.1(a)). Further, the LPS was reactive with monoclonal antibodies specific for F. 
tularensis O-antigen (BioDesign; Fig.1(b)).  
 
The O-antigen was isolated from type A F. tularensis strain OSU 10 LPS by acid 
hydrolysis. Briefly, LPS was suspended in 1 % acetic acid and heated at 100 °C for 2.5 
hours, the lipid portion was removed by centrifugation at 12000 g for 20 minutes, and the 
supernatant containing O-antigen was freeze dried. The O-antigen was further purified by 
gel filtration chromatography. Lyophilized O-antigen was suspended in 50 mM 
ammonium acetate and passed through a Toyopearl HW-50F (Supelco) gel filtration 
column. Elution of polysaccharide was monitored by refractive index. The three major 
fractions were pooled separately and freeze dried. The O-antigen fraction, eluting just 
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after the void volume, was identified by its immunoreactivity with monoclonal antibodies 
specific for F. tularensis O-antigen and by its 1H NMR spectrum (Fig.2). A 2D 1H - 13C 
heteronuclear multiple-quantum coherence (HMQC) spectrum of the O-antigen was 
obtained on a Varian Inova 600 NMR spectrometer at 30 °C with continuous wave water 
presaturation using the standard pulse sequence on the instrument. 
 
The 1H NMR spectrum of O-antigen from type A F. tularensis strain OSU 10 was 
almost identical to that shown for the O-antigen of F. tularensis LVS (Fig.2; (Conlan et 
al. 2002), except for some low intensity signals between 3.7 and 4 ppm indicating a small 
amount of contamination by another polysaccharide (see below). For a more definitive 
check on the identity between the O-antigen from the two subspecies of F. tularensis the 
HMQC spectrum of the type A F. tularensis strain OSU 10 O-antigen was compared to 
the HSQC spectrum reported for F. tularensis LVS (Fig.2; (Conlan et al. 2002). Both 
types of 2D spectra correlate chemical shifts of directly bonded carbons and protons. All 
of the signals present in the LVS strain were present at the same carbon and proton 
chemical shifts in the strain OSU 10 indicating that the structure of the two 
polysaccharides are the same.  The signal for the C-1, H-1 of the N-acetyl-quinovosamine 
was rather weak because it was under the water peak that had been suppressed.  Some 
additional signals were observed in the HMQC spectrum of strain OSU 10.  These 
probably come from a small amount of contamination with the glucans reported earlier 
(Conlan et al. 2003). Judging from the low intensity of the signals in the 1D spectrum 
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corresponding to the putative C-6, H-6 signal at 61 ppm, 3.9 ppm for glucose the 
contamination is quite minor. 
 
The NMR data suggest that type A F. tularensis strain OSU 10 has an identical O-
antigen as that of type B F. tularensis strain 15 and F. tularensis LVS. The present study 
supports the theory that strains of both type A and type B F. tularensis have identical O-
antigen repeats (Conlan et al. 2002; Vinogradov & Perry 2004). Further analysis of O-
antigen structure from additional strains should confirm this. Thus, it appears that 
different mechanisms of protection are required to resolve infections caused by virulent 
strains of type A and type B F. tularensis (Fulop et al. 2001).  
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Figure 1. Silver staining of F. tularensis subspecies tularensis strain OSU 10 LPS 
separated on a 12 % polyacrylamide gel (a). Western blot of F. tularensis subspecies 
tularensis strain OSU 10 LPS developed with monoclonal antibodies specific to F. 
tularensis O-antigen (b).  
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Figure 2. Superposition of the 1D 1H NMR and 2D 1H – 13C HMQC spectrum of the O-
antigen of F. tularensis subspecies tularensis strain OSU 10.  Signals are labeled with 
sugar and proton/carbon number corresponding to the structure shown using the HSQC 
spectrum for F. tularensis LVS (Conlan et al. 2002) and the chemical shifts reported for 
F. tularensis strain 15 (Vinogradov et al. 1991).  
  93 
 
 
 
 
 
 
 
 
 
  94 
 
 
 
 
References  
 
Conlan, J. W., H. Shen, A. Webb, and M. B. Perry, 2002 Mice vaccinated with the O-
antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine 
serum albumin develop varying degrees of protective immunity against systemic 
or aerosol challenge with virulent type A and type B strains of the pathogen. 
Vaccine 20: 3465-3471. 
Conlan, J. W., E. Vinogradov, M. A. Monteiro, and M. B. Perry, 2003 Mice 
intradermally-inoculated with the intact lipopolysaccharide, but not the lipid A or 
O-chain, from Francisella tularensis LVS rapidly acquire varying degrees of 
enhanced resistance against systemic or aerogenic challenge with virulent strains 
of the pathogen. Microb.Pathog. 34: 39-45. 
Fulop, M., P. Mastroeni, M. Green, and R. W. Titball, 2001 Role of antibody to 
lipopolysaccharide in protection against low- and high-virulence strains of 
Francisella tularensis. Vaccine 19: 4465-4472. 
  95 
 
Fulop, M. J., T. Webber, R. J. Manchee, and D. C. Kelly, 1991 Production and 
characterization of monoclonal antibodies directed against the lipopolysaccharide 
of Francisella tularensis. J.Clin.Microbiol. 29: 1407-1412. 
Petersen, J. M., M. E. Schriefer, L. G. Carter, Y. Zhou, T. Sealy et al.  2004 Laboratory 
analysis of tularemia in wild-trapped, commercially traded prairie dogs, Texas, 
2002. Emerg.Infect.Dis. 10: 419-425. 
Prior, J. L., R. G. Prior, P. G. Hitchen, H. Diaper, K. F. Griffin et al.  2003 
Characterization of the O antigen gene cluster and structural analysis of the O 
antigen of Francisella tularensis subsp. tularensis. J.Med.Microbiol. 52: 845-851. 
Vinogradov, E., and M. B. Perry, 2004 Characterisation of the core part of the 
lipopolysaccharide O-antigen of Francisella novicida (U112). Carbohydr.Res. 
339: 1643-1648. 
Vinogradov, E. V., A. S. Shashkov, Y. A. Knirel, N. K. Kochetkov, N. V. 
Tochtamysheva et al.  1991 Structure of the O-antigen of Francisella tularensis 
strain 15. Carbohydr.Res. 214: 289-297. 
Yi, E. C., and M. Hackett, 2000 Rapid isolation method for lipopolysaccharide and lipid 
A from gram-negative bacteria. Analyst 125: 651-656. 
  96 
 
 
CHAPTER V 
 
 
 
Lipopolysaccharide microarrays for the detection of antibodies 
 
Abstract 
 
Lipopolysaccharide (LPS) is the major component of Gram-negative bacterial 
outer membrane. LPS is immunogenic and shows species/strain specificity. The 
demonstration of anti-LPS antibodies in clinical samples is of diagnostic value in certain 
Gram-negative bacterial infections. In the present study we explored the possibility of 
immobilizing LPS isolated from different bacteria in a microarray format for the 
detection of anti-LPS antibodies. LPS was successfully immobilized on nitrocellulose 
coated glass slides, preserving the accessibility of epitopes for antibody binding. 
Specificity of the LPS arrays was established using four different monoclonal antibodies 
specific for Escherichia coli O111, E.coli O157, Francisella tularensis and Salmonella 
typhimurium O-antigens and a panel of LPS preparations. The detection limit of 
antibodies was found to be 10 ng/ml, which is about a 100 fold greater sensitivity 
compared to conventional immunofluorescence assays. Furthermore, using LPS arrays, 
tularemia positive canine serum samples could be differentiated from negative samples 
based on the presence of significantly higher levels anti-Francisella tularensis LPS 
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antibodies in positive samples. LPS arrays will facilitate simultaneous screening of 
samples against multiple antigens and are expected to find applications in diagnostics and 
seroepidemiology.  
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Introduction 
 
Gram–negative bacteria represent an important group of human and animal 
pathogens. These bacteria are characterized by the presence of an outer membrane with 
unique lipopolysaccharide (LPS) molecules. LPS is an amphipathic molecule and 
consists of three regions – a hydrophobic lipid-A, hydrophilic core oligosaccharide and 
an outer polysaccharide O-antigen.  LPS plays a major role in pathogenesis (Lerouge and 
Vanderleyden, 2002) and the O-antigen part of LPS has been shown to be immunogenic 
(Jauho et al., 2000; Weintraub, 2003). Certain species of Gram-negative bacteria, 
especially Salmonella spp. and Escherichia coli, show high diversity in their O-antigen 
structure (Lerouge and Vanderleyden, 2002) and are identified by classic serotyping 
using antibodies specific for O-antigen (Poxton, 1995; Lerouge and Vanderleyden, 2002). 
Different serotypes within a species of Gram-negative bacteria vary in their pathogenicity 
and epidemiology. Certain serotypes are found to be associated with certain diseases, 
particularly in case of E. coli (Poxton, 1995). Gram-negative bacterial infections can be 
diagnosed by detecting antibodies specific to LPS (Poxton, 1995). Diagnosis of an 
infection and establishing the serotype of the bacterium involved is important not only for 
initiation of proper treatment but also for epidemiological studies (Poxton, 1995).  
Currently, clinical samples are screened for the presence of specific antibodies using 
immunological assays such as agglutination tests or ELISA (Jauho et al., 2000) . The 
presence of a large number of pathogenic Gram–negative bacteria along with numerous 
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serotypes within certain species warrants a multiplex method for rapid diagnosis of 
Gram-negative bacterial infections.  
 
In the present study we tested the feasibility of using LPS arrays to detect specific 
antibodies to bacterial LPS. Microarray-based methods have been described for nucleic 
acids, proteins, and, recently for carbohydrates (Fukui et al., 2002; Wang et al., 2002).  In 
addition to being multiplexed and rapid, such methods require only small quantities of 
samples and reagents. The LPS arrays developed were found to be specific and sensitive. 
The method was also used to detect the presence of specific antibodies against 
Francisella tularensis in canine serum samples.  
 
Materials and Methods  
 
Lipopolysaccharides and Antibodies  
 
Lipopolysaccharide from Francisella tularensis subspecies tularensis was 
isolated using the Tri-reagent method described previously (Yi and Hackett, 2000). LPS 
preparations from Escherichia coli O111:B4, E. coli O26:B6, Klebsiella pneumoniae, 
Pseudomonas aeruginosa serotype 10, Salmonella enteritidis, Salmonella typhimurium, 
Shigella flexneri serotype 1A were purchased from Sigma (St. Louis, MO). E. coli O157 
LPS was obtained from Nacalai Tesque, Inc. Japan. Commercial preparations of 
monoclonal antibodies (mABs) of IgG isotype specific for E. coli O157, F. tularensis and 
S.  typhimurium O-antigens were  obtained from BioDesign (Saco, ME) and mABs of 
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IgM isotype specific for E. coli O111 O-antigen were obtained from Abcam (Cambridge, 
MA). Alexa Fluor 488 labeled goat anti-mouse IgG and anti-mouse IgM antibodies 
(Molecular Probes, Eugene, OR) or FITC-labeled goat anti-dog IgG antibodies 
(Kirkegaard and Perry Laboratories, Gaithersburg, MD) were used as secondary 
antibodies.  
Clinical samples  
 
Five samples of canine serum (PS1 to PS5) collected from clinical cases of 
tularemia and positive for Francisella tularensis antibodies with known 
microagglutination titer (titer > 20) and two canine serum samples (NS1 and NS2) 
negative for F. tularensis antibodies (microagglutination titer < 20)  were obtained from 
the laboratory of R. J. Morton. 
Printing and Scanning of LPS arrays 
 
LPS arrays were printed using a microarray printer (OmniGrid, Gene Machines, 
CA, USA) on nitrocellulose coated glass slides (SuperNitro microarray substrates, 
Telechem International Inc., CA, USA). Each LPS sample was resuspended in buffer 
(Tris 20 mM pH 7.5, NaCl 100 mM and MgCl2 5 mM) and printed with a spot spacing of 
500 µm. The spot size was approximately 200 µm.  For LPS immobilization studies, two 
fold dilutions (1 to 0.031 mg/ml) of fluorescein isothiocyanate (FITC) conjugated E. coli 
O111:B4 LPS were printed in triplicate. For antibody binding experiments, LPS isolated 
from different bacteria were printed either in a two fold dilution series (1 to 0.031 mg/ml) 
(Fig. 2) or at a single concentration of 1 mg/ml (Fig. 3, 4, and 6) in replicates of six spots 
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per dilution. Additionally, mouse immunoglobulins (0.1 mg/ml; Fig. 3) or canine serum 
(1:10 dilution; Fig. 6) were printed as positive controls. The slides were scanned using a 
microarray scanner (ScanArray Express, Perkin-Elmer, MA, USA), and the images 
analyzed using Genepix Pro 5.0 software (Axon Instruments Inc., CA, USA).  
Antibody binding experiments  
 
The printed slides were first blocked in 2% BSA in PBS (pH 7.4) for 30 minutes, 
rinsed twice with PBS containing 0.05% Tween 20 (PBS-T) followed by a rinse in PBS 
and spin dried. The slides were then incubated with anti-LPS monoclonal antibodies (3 
µg/ml) or serum samples (1:50 dilution) in PBS for 30 to 45 minutes at room 
temperature. After incubation, the slides were washed thrice with PBS-T for 10 minutes 
each. The slides were flooded with Alexa Fluor488 labeled (unless otherwise specified) 
secondary antibodies (5 µg/ml in PBS) for 30 minutes and subsequently washed thrice in 
PBS-T followed by one wash in PBS and dried as described above. The slides were then 
scanned and the images were analyzed by Genepix Pro 5.0 software.  
Microtiter plate based immunoassays 
 
Immunoassays were done as previously described (Fulop et al., 1991; Conlan et 
al., 2002) with modifications.  Briefly, 96-well flat-bottom black microtiter plates 
(Microfluor1, Nalge Nunc International, Rochester, NY) were coated with LPS (10 
µg/ml, 200µl per well) in carbonate buffer pH 9.6  at 37° C for 3h followed by overnight 
incubation at 4° C. The LPS solution was aspirated and wells were blocked with 2% BSA 
in PBS at room temperature for 1h. Wells were then washed thrice in PBS-T for five 
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minutes each and incubated with different concentrations (0.001, 0.01, 0.1 and 1 µg/ml in 
PBS; 100 µl per well) of anti-LPS mABs in triplicate at room temperature for 1h. After 
incubation the wells were washed thrice with PBS-T for 10 minutes each.  Then, Alexa 
Fluor488 labeled goat-anti-mouse IgG antibodies in PBS (5 µg/ml; 100 µl per well) was 
added and incubated at room temperature for 1h. Wells were washed thrice with PBS-T 
followed by one wash in PBS and fluorescence was recorded using a plate reader 
(POLARstar Optima, BMG Labtechnologies Inc., Durham, NC).  
Statistical analysis  
 
All data presented on LPS arrays were representative of at least three independent 
experiments. Fluorescence signals were presented as mean ± standard deviation after 
subtracting the background signal. In order to compare results from different slides, the 
fluorescence signals were further normalized as ratios of the fluorescence signal values 
obtained for mouse immunoglobulins (0.1 mg/ml; Fig. 3) or a canine serum (1:10 
dilution; Fig. 6) printed on the same slides as positive controls. Data were analyzed using 
one-way ANOVA and Tukey’s test. Means were considered significantly different if          
P < 0.05.  
Results  
 
Immobilization of LPS on nitrocellulose coated slides  
 
 Printing of FITC labeled E. coli O111:B4 LPS on nitrocellulose coated slides 
produced a concentration dependent fluorescence signal (Fig. 1A & C). Repeated 
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washings did not result in a significant loss of fluorescence signal (Fig. 1B & D) 
indicating the stable immobilization of LPS on nitrocellulose coated surface without the 
need for any additional chemical conjugation. Also, the LPS spot morphology was found 
to be uniform enabling accurate quantification of the signals. 
Antibody binding experiments  
 
Monoclonal antibodies (3 µg/ml) successfully bound to F. tularensis LPS 
immobilized on nitrocellulose coated slides but not E .coli O111 LPS (Fig. 2). The 
fluorescence resulting from binding of antibodies corresponded to the LPS concentrations 
printed. LPS concentration of 0.0625 mg/ml and above resulted in significantly higher 
fluorescence compared to controls. Figure 3 shows the specific recognition of O-antigens 
on LPS arrays by monoclonal antibodies. Monoclonal antibodies of IgG isotype for O-
antigens of E. coli O157, F. tularensis and S. typhimurium specifically reacted with the 
respective LPS but not with other lipopolysaccharides (LPSs) printed on the same slide. 
Similarly, monoclonal antibodies of IgM isotype specific for E. coli O111 O-antigen 
reacted only with the E. coli O111 LPS on arrays.  
 
The sensitivity of LPS arrays for detection of antibodies was compared to that of 
conventional microtiter plate based immunofluorescence assay using monoclonal 
antibodies (Fig. 4&5). As low as 10 ng/ml antibodies against F. tularensis (Fig. 4A) and 
S. typhimurium LPS (Fig. 4B) could be detected using LPS arrays. The lowest 
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concentrations of F. tularensis and S. typhimurium mABs that could be detected in 
conventional assay was 1 µg/ml (Fig. 5A&B).  
 
LPS arrays were successfully employed to detect antibodies in clinical samples 
(Fig. 6). Arrays containing a panel of LPSs including F. tularensis LPS were exposed to 
1:50 dilution of canine serum samples that tested either positive (titer >20) or negative 
(titer <20) for F. tularensis antibodies by microagglutination test. The arrays were 
developed with FITC-labeled anti-canine secondary antibodies. All five positive samples 
(PS1, PS2, PS3, PS4 and PS5) tested showed significantly higher level of anti-F. 
tularensis LPS antibodies compared to two negative samples (NS1&NS2; Fig. 6). Certain 
serum samples (PS3, PS4, NS1 and NS2) showed a slight reaction with E. coli O26 LPS 
as evidenced by the small increase in fluorescence (Fig. 6). Sample PS1 showed higher 
levels of antibodies against Klebsiella pneumoniae and E. coli O111 LPS (Fig. 6). This 
could be due to the presence of low concentrations of serum antibodies against E. coli 
and K. pneumoniae LPS.  
 
 
Discussion  
 
LPS is an important component of the outer membrane of Gram-negative bacteria. 
It constitutes about 10 - 15% of molecules in the outer membrane and covers up to 75% 
of Gram-negative bacterial surface (Lerouge and Vanderleyden, 2002; Caroff and 
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Karibian, 2003).  Approximately 2 million molecules of LPS are estimated to be present 
on the surface of E. coli (Raetz, 1990).  The structure of lipid-A is conserved among 
Gram-negative bacteria, whereas the O-antigen is species/strain specific (Lerouge and 
Vanderleyden, 2002). The diversity and specificity of O-antigen is attributed to its unique 
sugar composition and number of possible glycosidic linkages (Lerouge and 
Vanderleyden, 2002; Caroff and Karibian, 2003).  LPS are important antigens of Gram-
negative bacteria (Jauho et al., 2000; Peula-Garcia et al., 2002) and induce specific 
antibody responses during infection. The antibodies directed against O-antigen 
component of LPS have been shown to be species / serotype specific (Jauho et al., 2000).   
 
In the present study, we evaluated the use of LPS microarrays printed on 
nitrocellulose coated slides as a platform for the detection of antibodies. The adsorption 
and immobilization of LPS on nitrocellulose coated slides were found to be stable 
without the need for any additional chemical conjugation (Fig.1). The presence of nitro 
groups renders the nitrocellulose surface hydrophobic (Wang, 2003). Binding of LPS on 
nitrocellulose-coated slides is likely to involve hydrophobic interaction between the lipid-
A and nitrocellulose surface. The use of nitrocellulose surface will possibly help to 
overcome the poor reproducibility associated with passive adsorption of LPS onto 
microplate surface (polystyrene / polypropylene) in ELISA (Poxton, 1995; Jauho et al., 
2000).  
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LPS arrays printed on nitrocellulose-coated slides retained their antigenic 
properties as evidenced by the binding of antibodies to them (Fig. 2). The specificity of 
antibody binding and the ability of different antibody isotypes to bind LPS arrays were 
demonstrated by exposing arrays containing a number of LPSs from different bacteria on 
the same slide, to O-antigen specific monoclonal antibodies. Specific recognition of 
immobilized LPS was observed for both IgG and IgM classes of antibodies (Fig. 3). The 
accessibility of epitopes on immobilized LPS for IgM antibodies is important as 
antibodies against LPS are biased towards the IgM isotype (Trautmann et al., 1998).   
The LPS arrays were capable of detecting antibody concentrations as low as 10 ng/ml 
(Fig. 4A&B) which is about a 100 fold improvement in sensitivity over conventional 
immunofluorescence assays (Fig. 5A&B) (Goldsby, 2003). It has been suggested that 
binding equilibrium is easily achieved with microarrays, as the binding of ligands onto a 
small spot of immobilized molecules does not significantly alter the concentration of 
ligands in solution, resulting in greater sensitivity (Wang, 2003).  
 
Experiments were also done to test the intra and inter-slide variability and shelf 
life of LPS arrays for antibody detection (data not shown). Coefficients of variation (CVs 
were calculated as the standard deviation of fluorescence value divided by the mean and 
expressed in percentage) for intra-slide and inter-slide variability were 6.98% (n=18 
spots) and 16.21% (n=4 slides) respectively. In order to test the shelf-life, LPS arrays 
stored at room temperature for 4 weeks were compared with freshly printed arrays by 
simultaneously developing both the sets with primary and labeled secondary antibodies. 
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The stored LPS arrays were found to be stable, although there was a slight decrease in the 
fluorescence signals compared to freshly printed slides (CV of 24.80%; n=4 slides), 
suggesting some degree of LPS degradation on storage.  
 
Demonstration of anti-LPS antibodies in clinical samples is an indirect indication 
of infection and has been used in the diagnosis of many infections caused by Gram-
negative bacteria such as Salmonella typhi  (Herath, 2003), Brucella spp. (Al Dahouk et 
al., 2003), enterohemorrhagic E. coli O157, O26 and O111 (Ludwig et al., 2002; 
Tsutsumi et al., 2004), Chlamydia spp. (Brade et al., 1994; Priya et al., 2003), Leptospira 
interrogans (Priya et al., 2003), F. tularensis (Aronova and Pavlovich, 2000), Yersinia 
enterocolitica (Thibodeau et al., 2001), Shigella spp. (Li et al., 1993), Vibrio cholerae 
(Chang and Sack, 2001), Pseudomonas aeruginosa (Schaad et al., 1990)and  Bordetella 
pertussis (Trollfors et al., 2001). In this study, the suitability of LPS arrays for detection 
of antibodies from clinical samples was successfully demonstrated using canine serum 
samples. The serum samples used were known to be either positive (titer>20) or negative 
(titer<20) for F. tularensis antibodies based on microagglutination test. Using LPS 
arrays, significantly higher levels of anti- F. tularensis antibodies could be detected in all 
five positive samples as compared to the two negative samples (Fig. 6). Generally, 
clinical samples are screened against one or two antigens chosen based on clinical 
symptoms and patient history, using conventional assays like agglutination tests or 
ELISA to arrive at a diagnosis.  The LPS array approach allows rapid screening of a 
clinical sample against multiple Gram-negative bacterial infections with the possible 
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identification of bacterial serotypes. This could become crucial to initiate an appropriate 
treatment. Although, technically it may be possible to include most of Gram-negative 
bacterial LPS on a single slide, the intrinsic limitations of anti-LPS antibody detection 
may limit the actual number of different LPS that can be included in an array. Some 
bacterial LPS antigens show cross reaction with other bacterial LPS (Mitov et al., 2003) 
and it is not possible to diagnose all Gram-negative bacterial infections based on anti-
LPS antibodies. However, inclusion of protein and carbohydrate antigens along with LPS 
may increase the scope of this approach to include other infectious agents.  
 
Other potential areas of application of LPS arrays are in the field of 
seroepidemiology. The importance of anti-LPS antibodies has been demonstrated in the 
seroepideomiology of many bacterial diseases, such as Vibrio cholerae (Suthienkul et al., 
1992), Klebsiella spp. (Trautmann et al., 2004), E. coli O157 (Evans et al., 2000), typhoid 
fever (House et al., 2001), Chlamydia spp. (Blatz et al., 2001) and Shigella spp. (Hyams 
et al., 1995). LPS arrays allow simultaneous seroepidemiology of a large number of 
Gram-negative bacterial diseases in a population. This will help in acquisition of valuable 
information on disease prevalence for well planned disease control programs.   
 
Other promising applications of LPS arrays include evaluation of intravenous 
immunoglobulin (IVIG) preparations for prophylactic or therapeutic use in sepsis / 
endotoxemia associated with Gram-negative bacterial infections (Trautmann et al., 1998). 
Also, LPS arrays may be used to assess the level / quality of anti-LPS antibodies in 
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patients with sepsis or prior to surgery, as the high level of anti-LPS antibodies is an 
indicator of favorable prognosis in sepsis patients (Poxton, 1995). 
 
Microarray-based immunoassays offer several advantages over conventional 
immunological assays. These assays are multiplexed in nature allowing rapid and 
simultaneous screening of a clinical sample against multiple antigens. In addition, these 
assays show greater sensitivity compared to conventional assays. Apart from these 
advantages, microarray-based assays require only small quantities of samples and 
reagents.   
 
Conclusions 
 
This study demonstrates the applicability of LPS arrays for antibody detection. 
LPS arrays are likely to find applications in disease diagnosis, seroepidemiology, 
evaluation of intravenous immunoglobulin preparations and assessment of patients with 
sepsis / endotoxaemia or prior to surgery. The major advantage of LPS arrays over 
conventional assays is the ability to simultaneously screen a sample against multiple 
antigens.  
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Figure 1. Immobilization of bacterial LPS on nitrocellulose coated slide. Two-fold 
dilutions (1 to 0.03125 mg/ml) of FITC-labeled E. coli O111 LPS in buffer (Tris 20 mM 
pH 7.5, NaCl 100 mM and MgCl2 5 mM) were printed in triplicate on nitrocellulose 
coated slides and scanned for fluorescence (A). The slides were washed once in PBS-
Tween 20 (0.05%) pH 7.4 followed by two washes in PBS alone and scanned again (B). 
Fluorescence signals before and after wash did not differ significantly (C & D).  The 
fluorescence signals were normalized as ratios of the highest fluorescence value for each 
slide. The data points represent mean fluorescence value + SD of three spots for each 
LPS concentration (three slides). 
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Figure 2.  Recognition of surface immobilized LPS by monoclonal antibodies. Two-
fold dilutions (1 mg/ml to 0.03125 mg/ml) of F. tularensis and E. coli O111 LPS were 
printed in replicates of six on nitrocellulose coated slides. Slides were incubated with 
monoclonal antibody (3 µg/ml in PBS) specific for F. tularensis O-antigen. The arrays 
were developed with Alexa fluor 488 labeled goat anti-mouse secondary antibodies (5 
µg/ml). F. tularensis antibody recognized the F. tularensis LPS in a concentration 
dependent manner. The fluorescence signals were normalized as ratios of the highest 
fluorescence value for each slide. The data points represent mean fluorescence value ± 
SD of six replicate spots for each LPS concentration (four slides). 
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Figure 3. Binding specificity of O-antigen monoclonal antibodies to LPS arrays.       
A panel of nine LPS preparations isolated from different bacteria was printed in 
replicates of six at a concentration of 1 mg/ml on nitrocellulose coated slides. The slides 
were incubated with 3 µg/ml of monoclonal antibodies (IgG isotype) specific for F. 
tularensis, S. typhimurium, E. coli O157 O–antigens or monoclonal antibody (IgM 
isotype) specific for E. coli O111 O-antigen and developed with Alexa Fluor 488 labeled 
goat anti-mouse secondary antibody (5 µg/ml). Antibodies specifically recognized the 
respective O-antigens as evidenced by the significant increase in fluorescence in each 
array. The fluorescence signals were normalized as ratios of fluorescence signal from 
mouse immunoglobulins (0.1 mg/ml) printed on the same slide as positive controls after 
background subtraction. The results are representative of three independent experiments. 
The data points represent mean ± SD of six replicate spots for each LPS preparation. 
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Figure 4. Detection limit of antibodies using LPS arrays 
Frncisella tularensis and S. typhimurium LPS were printed at a concentration of 1 mg/ml 
in replicates of six on nitrocellulose coated slides. Slides were incubated with different 
concentrations of monoclonal antibodies (1, 0.1, 0.01 and 0.001 µg/ml in PBS) specific 
for F. tularensis (A) or S. typhimurium O-antigen (B). The arrays were developed with 
Alexa fluor 488 labeled goat anti-mouse secondary antibodies (5 µg/ml). The results are 
representative of three independent experiments. The data points represent mean ± SD of 
six replicate spots for each LPS preparation. 
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Figure 5. Detection limit of antibodies for microtiter assays 
Microtiter plate wells were coated either with F. tularensis or S.  typhimurium LPS (10 
µg/ml) in carbonate buffer. Wells were incubated in triplicate with monoclonal antibodies 
(1, 0.1, 0.01 and 0.001 µg/ml in PBS) specific for F. tularensis (A) or S. typhimurium O-
antigen (B). Binding of primary antibodies was detected using Alexa fluor 488 labeled 
goat anti-mouse secondary antibodies (5 µg/ml). The results are representative of two 
independent experiments. The data points represent mean ± SD of triplicate wells for 
each antibody concentration. 
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Figure 6. Detection of F. tularensis anti-LPS antibodies in serum samples.  
A panel of nine LPS preparations isolated from different bacteria was printed in 
replicates of six at a concentration of 1 mg/ml on nitrocellulose slides and incubated 
either with canine serum samples (dilution 1:50) positive for F. tularensis antibodies 
(microagglutination titer >20) or with canine serum samples negative (titer <20) for F. 
tularensis antibodies.  Five positive and two negative samples were tested. The slides 
were developed with FITC labeled goat anti-canine secondary antibodies (5 µg/ml). The 
level of specific F. tularensis antibodies were significantly higher in positive samples 
(PS1 to 5) compared to negative samples (NS1&2). The fluorescence signals were 
normalized as ratios of fluorescence signal from canine serum (1:10 dilution) printed on 
the same slide and developed with FITC labeled anti-canine antibodies after background 
subtraction. The results are representative of three independent experiments. The data 
points represent mean + SD of six replicate spots for each LPS preparation. 
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Chapter VI 
Bacterial cell microarrays for the detection and characterization of 
antibodies against surface antigens 
 
Abstract  
 
Bacterial cell surface antigens interact with the host immune system resulting in 
the production of antibodies. Detection of antibodies against surface antigens has 
applications in diagnosis of many bacterial infections, assessment of immune status and 
epidemiological studies. We developed a microarray platform, for antibody detection, by 
printing Gram-negative and Gram-positive whole bacterial cells on nitrocellulose coated 
glass substrates. Antibody binding was detected using fluorophore labeled secondary 
antibodies.  The sensitivity of antibody detection was found to be 0.1µg/ml. Using 
bacterial cell microarrays it was also possible to successfully detect antibodies against 
Francisella tularensis in canine serum samples declared positive for tularemia based on 
microagglutination antibody titer. Use of bacterial cells as the antigen source in 
immunoassays has the advantages of simulating in vivo presentation of surface antigens 
and also eliminating the need for antigen purification. The microarray format gives the 
added advantage of simultaneous detection of antibodies against multiple bacteria 
employing only small amounts of samples and reagents.  
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Introduction 
 
 
Demonstration of antibodies to bacterial surface antigens has found applications 
in disease diagnosis (Watanabe et al. 2001; Itoh et al. 2002), epidemiological studies and 
immune status assessment (Rossi et al. 2003). Antibodies produced against surface 
antigens have a higher probability of neutralizing bacteria, therefore detection of these 
antibodies can serve as an indicator of the protective immune response (Watanabe et al. 
2001). Conventional immunoassays usually employ purified antigens for antibody 
detection. Production of purified antigens is often labor intensive (Itoh et al. 2002). The 
use of whole cells in immunoassays avoids the need for antigen purification and offers 
the advantage of presenting surface antigens in their native form thereby simulating 
antigen-antibody reactions in vivo (Watanabe et al. 2001). Whole cells have been used in 
the detection of antibodies against various bacteria (Verschoor et al. 1990; Marcotte & 
Lavoie 1993; Lamari et al. 1999; Watanabe et al. 2001; Itoh et al. 2002). However, 
immobilization of whole cells on microtiter plates has been reported to be variable 
resulting in poor reproducibility (Poxton 1995).  
 
In the present study, we describe a microarray-based multiplex immunoassay for 
detection of antibodies to surface antigens of several bacteria. Formalin inactivated 
bacterial cells were printed on nitrocellulose-coated glass slides using a standard 
microarray instrument, and used for antibody detection. Sensitivity of this assay was 
established using monoclonal antibodies and was found to be 0.1µg/ml of antibody. 
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Successful detection of pathogen specific antibodies against Francisella tularensis in 
canine serum samples was also achieved.  The microarray format requires only minimal 
amount of samples and reagents. It also allows for the simultaneous screening of a 
sample for the presence of antibodies against numerous bacteria. 
 
 
 Materials and Methods 
 
Bacteria 
 
Gram-negative bacteria Escherichia coli (ATCC 25922), Francisella tularensis 
subsp. tularensis, Klebsiella pneumoniae, Salmonella typhimurium (ATCC 14028), and 
Gram-positive bacteria Enterococcus faecalis, Staphylococcus aureus (ATCC 29523), 
Staphylococcus epidermidis, Streptococcus pyogenes (ATCC 19615) and Listeria 
monocytogenes were provided by R. J. Morton. Bacteria were grown on suitable agar 
media and inactivated using 0.5% formol saline. The inactivated cells were washed three 
times in PBS pH 7.4 and resuspended in PBS. The numbers of bacteria in samples were 
determined by flow cytometry using a bacteria counting kit (Molecular Probes, Eugene, 
OR) asper manufacturer’s instructions.  
   
Antibodies and serum samples 
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Monoclonal antibodies to F. tularensis O-antigen, Salmonella O-antigen (B 
group), Staphylococcus aureus, and Listeria monocytogenes were obtained from a 
commercial source (Biodesign, Saco, ME). Canine serum samples were obtained from 
the laboratory of R. J. Morton.  
Printing and scanning of bacterial cell arrays 
 
 
Bacterial cells were suspended in PBS containing 20% Ficoll 400 (Fisher 
Scientific, Fair Lawn, NJ) and 4% glycerol to get an approximate cell density of 
5x1011cells/ml. In case of Streptococcus pyogenes, the cells were suspended in PBS 
containing 30 % Ficoll 400 and 4% glycerol to get an approximate cell density of 5x109 
cells/ml. Bacterial cells were printed on microarray substrates using a microarray printer 
(OmniGrid, Gene Machines, CA, USA). A 1:50 dilution of a canine serum sample was 
printed as positive control on all slides used in antibody detection from serum samples 
(Fig. 6) for the purpose of data normalization. After printing, the cell arrays were left on 
the printer at room temperature and 70% humidity for 30 minutes to enable bacterial cells 
to adsorb onto the substrate.  
 
The slides were scanned using a microarray scanner (ScanArray Express, Perkin-
Elmer, MA, USA), and the images analyzed using Genepix Pro 5.0 software (Axon 
Instruments Inc., CA, USA).  
Evaluation of microarray substrates for bacterial immobilization 
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Various commercially available microarray substrates - nitrocellulose coated glass 
slides (SuperNitro microarray substrates), SuperEpoxy slides, SuperAldehyde slides 
(Telechem International Inc., CA), poly–L-lysine slides (CEL Associates Inc., TX), and 
glass slides were tested for their suitability for immobilization of whole bacterial cells. 
Francisella tularensis and Staphylococcus aureus were stained with BacLight Green 
fluorescent bacterial stain (Molecular Probes, Eugene, OR) asper manufacturer’s 
instructions and thoroughly washed in PBS to remove unbound dye. Stained cells were 
resuspended in PBS containing 20% Ficoll 400 and 4% glycerol and printed on 
microarray substrates. Printed slides were scanned to record fluorescence signals. Then 
the slides were washed thrice in PBS containing 0.05% Tween 20 (PBS-T) followed by 
once in PBS, each 10 minutes and spin dried. Slides were again scanned to record the 
fluorescence signals.  
 
Detection of antibodies to cell surface antigens 
 
 
The printed slides were first blocked with 2% BSA in PBS (pH 7.4) for 30 
minutes, rinsed thrice with PBS-T and spin dried. The slides were then incubated with 
monoclonal antibodies or serum samples diluted in PBS at various concentrations (as 
specified in figure legends) for 30 to 45 minutes at room temperature. After incubation, 
the slides were washed thrice for 10 minutes each with PBS-T. The slides were then 
incubated with Alexa Fluor 488 labeled (unless otherwise specified) secondary antibodies 
  134 
 
(5µg/ml in PBS) for 30 minutes and subsequently washed and dried as described above. 
The slides were then scanned and the images were analyzed by Genepix Pro 5.0 software.  
 
Statistical analysis 
 
 
Data were analyzed using one way ANOVA and the means were compared using 
Tukey’s test. Statistical significance was determined at 95% (P<0.05). Results presented 
are representative of two or more independent experiments and are shown as mean ± 
standard error after background subtraction. Results from experiments using canine 
serum were normalized to the positive control (canine serum printed at a dilution of 1:50 
on the respective slides) before data analysis (Fig. 6).  
 
 
Results  
 
 
Both Gram-negative bacteria (F. tularensis) and Gram-positive bacteria 
(Staphylococcus aureus) were found to stably adsorb on to the nitrocellulose surface (Fig. 
1). Repeated washings did not result in a significant loss of fluorescence signal for F. 
tularensis. However, there was a statistically significant (P < 0.05) loss of fluorescence 
signal after wash in case of S.  aureus (Fig. 1C).  The bacteria did not bind as well to 
other surfaces tested such as poly-L-lysine coated surface, glass surface, SuperAldehyde, 
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SuperEpoxy substrates and Hydrogel NHS Ester slides.  Results for poly-L-lysine slides 
are shown in Fig 2. 
 
Fig. 3 shows the recognition of O-antigens by monoclonal antibodies on the 
surface of Gram-negative bacteria immobilized on nitrocellulose-coated slides. 
Monoclonal antibodies for O-antigen recognized F. tularensis whole cells immobilized 
on nitrocellulose coated glass slides but not other Gram-negative bacteria Salmonella 
typhimurium and Escherichia coli printed on the same slide (Fig. 3A). Monoclonal 
antibodies against Salmonella O-antigen (B Group) specifically bound Salmonella 
typhimurium cells printed on microarray slide (Fig. 3B).  
 
Recognition of Gram-positive bacterial surface antigens by specific monoclonal 
antibodies on cell arrays was tested (Fig. 4). Monoclonal antibodies specific for 
peptidoglycan of Staphylococcus aureus specifically recognized S. aureus cells but not 
Streptococci pyogenes and Listeria monocytogenes printed on the same slide (Fig. 4A). 
Similarly, monoclonal antibodies against L. monocytogenes specifically bound L. 
monocytogenes cells on cell arrays (Fig. 4B).  
 
Further the sensitivity of antibody detection using bacterial cell arrays was 
determined for both Gram-negative and Gram-positive bacteria (Fig. 5). The lowest 
concentration of monoclonal antibodies directed against the surface antigens of F. 
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tularensis (Fig. 5A) and L. monocytogenes (Fig. 5B) that could be detected using 
bacterial cell arrays was found to be 0.1µg/ml.  
 
Antibody detection in clinical samples using bacterial cell arrays was investigated 
(Fig. 6). Seven canine serum samples from known clinical cases of tularemia and positive 
for F. tularensis antibodies (microagglutination titer>20) and six canine serum samples 
negative for F. tularensis antibodies (microagglutination titer<20) were tested using 
bacterial cell arrays printed with F. tularensis whole cells and other Gram-negative and 
Gram-positive bacteria.  The level of anti- F. tularensis antibodies was significantly 
higher in tularemia positive samples compared to negative samples.   
 
 
Discussion 
 
 
The bacterial cell surface is decorated with an array of molecules such as outer 
membrane proteins, lipopolysaccharide, flagella (H-antigens), capsules and fimbriae or 
pili. Surface molecules are involved in bacterial adherence to host cells helping in 
establishing an infection. Antibodies directed against the bacterial surface antigens can 
neutralize the bacteria and afford protection particularly against certain extracellular 
bacteria (Haesebrouck et al. 2004).  
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In the present study we used bacterial cell arrays for the detection of antibodies against 
cell surface antigens. Bacterial cell arrays were fabricated and analyzed using standard 
microarray instruments. In order to keep bacterial cells in suspension during printing and 
prevent the cells from drying once printed, PBS containing Ficoll 400 (20%) and 4 % 
glycerol was used as printing buffer. Ficoll 400 increases the density of the solution and 
thereby maintains cells in suspension. The use of glycerol in printing buffer helps prevent 
total dehydration of cells after printing, preserves native structure of proteins and helps in 
maintenance of antigenicity of cell surface molecules (Howbrook et al. 2003). A similar 
strategy was used to print eukaryotic cells on microarray slides (Schwenk et al. 2002). A 
higher concentration of Ficoll 400 (30 %) was required to print Streptococcus pyogenes 
cells as these bacteria grow in chains. For the detection of antibodies against surface 
antigens it was found that printing a high density of bacterial cells (~5x1011cells/ml) was 
most effective. In case of S. pyogenes, cells were printed at an approximate density of 
5x109cells/ml. Due to their chain morphology, there is a possibility that the flow-
cytometric determination of the S. pyogenes cell count could have been underestimated, 
and thus the apparent low cell density.  
 
Both Gram-positive and Gram-negative bacteria strongly adsorbed onto 
nitrocellulose coated slides (Fig. 1). Fluorescently labeled F. tularensis and 
Staphylococcus aureus cells showed substantial adsorption onto nitrocellulose-coated 
slides. The loss of fluorescence signal upon washings was not significant for F. tularensis 
suggesting the stable adsorption of the cells (Fig. 1C). The loss of fluorescence in case of 
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S. aureus cells may suggest the saturation of spots on nitrocellulose surface (Fig. 1C). 
Bacterial cells did not bind as well to other microarry substrate surfaces tested such as 
poly-L-lysine coated slides (Fig. 2), SuperEpoxy Slides, SuperAldehyde slides and glass 
surface (results not shown). Poly-L-lysine coated slides have been used to immobilize 
eukaryotic cells (Schwenk et al. 2002).  
 
Binding of monoclonal antibodies to surface antigens on immobilized bacterial 
cells was detected using fluorophore labeled secondary antibodies for both Gram-positive 
and Gram-negative bacteria (Fig. 3 and 4). The sensitivity of antibody detection was 
found to be 0.1µg/ml for both S. typhimurium and L. monocytogenes (Fig. 5). For 
conventional immunofluorescence assays the sensitivity of antibody detection has been 
reported to be 1 µg/ml (Goldsby 2003). The affinity of antibodies and the density and 
distribution of epitopes will influence the sensitivity of detection. Since binding of 
ligands to small spots of immobilized molecules in microarrays does not significantly 
change the concentration of ligands in solution, binding equilibrium is easily achieved, 
resulting in greater sensitivity (Wang 2003).  
 
The variation within the slides and between the slides was determined. The 
coefficient of variation for intra-slide variability was found to be 7.7% for S. typhimurium 
and 8.96% for S. aureus (n=20 spots each). The inter-slide variations were 18.37% and 
13.22% for S. typhimurium and S. aureus respectively (n=6 slides). The cell arrays were 
found to be stable for at least two weeks when stored at 4ºC. 
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Using bacterial cell arrays it was possible to detect the higher levels of pathogen 
specific antibodies against F. tularensis (Fig.6) in serum samples obtained from seven 
known cases of canine tularemia (P1-P7) compared to known negative serum samples 
(N1-N6). In the serum samples tested, variable levels of antibodies were also observed 
against other bacteria printed on the slides.  Whole organisms have been used as test 
antigens for diagnosis of brucellosis, legionellosis, leptospirosis, lyme disease, 
Mycoplasma pneumonia, Q fever, tularemia and Helicobacter pylori infection,  (Evans & 
Brachman 1998; Watanabe et al. 2001). Antibody cross-reactivity among certain bacteria 
has been well documented (Nielsen et al. 2004) and is a major factor to be considered in 
the development of bacterial cell arrays. The inclusion of protein and carbohydrate 
antigens along with bacteria may help in this regard. Alternatively, immobilization of 
surface-engineered bacteria that display heterologous proteins/peptides or 
antibodies/affibody domains on a microarray substrate could provide novel tools in 
diagnostics and proteomics research (Samuelson et al. 2002; Wernerus & Stahl 2004).  
 
 
Conclusions 
 
 
The bacterial cell array-based immunoassays offer several advantages over 
conventional immunoassays such as agglutination tests or ELISA. Bacterial cell arrays 
are multiplex in nature and allow simultaneous screening of a sample against multiple 
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bacteria. These assays show greater sensitivity, require small amounts of samples and 
reagents and are likely to find applications in disease diagnosis, seroepidemiology, 
assessment of the immune status (Rossi et al. 2003), evaluation of intravenous 
immunoglobulin preparation (Lamari et al. 1999; Lamari et al. 2000a; Lamari et al. 
2000b), screening for potential anti-adhesion therapeutics (Ofek et al. 2003; Disney & 
Seeberger 2004; Thomas & Brooks 2004) and characterization of antibodies / ligands to 
surface antigens of bacteria.   
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Figure 1. Adsorption of bacterial cells onto nitrocellulose coated slides. Francisella 
tularensis (Ft), Staphylococcus aureus (Sa) and fluorescently  stained  F. tularensis (Ft-s) 
and S. aureus (Sa-s) were suspended in  PBS containing 20% Ficoll 400 and 4% glycerol 
at a cell density of ~ 5x1011 cells/ml and printed in replicates of 10 spots and scanned for 
fluorescence. Scanned images before and after wash are shown (A and B). Fluorescence 
signals before and after wash are presented (C).  The results are representative of two 
independent experiments (two slides per experiment). The data points represent mean 
fluorescence value + SEM. 
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Figure 2. Adsorption of bacterial cells on poly-L-lysine coated slide. Francisella 
tularensis (Ft), Staphylococcus aureus (Sa)  and fluorescent  stained  F. tularensis (Ft-s) 
and S. aureus (Sa-s) were suspended in  PBS containing 20% Ficoll 400 and 4% glycerol 
at a cell density of ~ 5x1011 cells/ml and printed in replicates of 10 spots and scanned for 
fluorescence. Scanned images before and after wash are shown (A and B). Fluorescence 
signals before and after wash are presented (C).  The results are representative of two 
independent experiments (two slides per experiment). The data points represent mean 
fluorescence value + SEM.  
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Figure 3. Binding of monoclonal antibodies to surface antigens of immobilized 
Gram negative bacteria. Cell suspensions of F. tularensis, S. typhimurium and E. coli 
were printed in replicates of twenty spots on nitrocellulose coated slides. Slides were 
incubated with monoclonal antibody (3µg/ml in PBS) specific for F. tularensis O-antigen 
(A) or S. typhimurium O-antigen (B). The bacterial cell arrays were developed with 
Alexa fluor 488 labeled goat anti-mouse secondary antibodies (5µg/ml). The results are 
representative of three independent experiments (two slides for each experiment). The 
data points represent mean fluorescence value + SEM.  
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Figure 4. Binding of monoclonal antibodies to surface antigens of immobilized 
Gram-positive bacteria. Cell suspensions of S. aureus, S.  pyogenes and L. 
monocytogenes were printed in replicates of twenty spots on nitrocellulose coated slides. 
Slides were incubated with monoclonal antibody (3 µg/ml in PBS) specific for 
peptidoglycan of S. aureus (A) or L. monocytogenes cells (B). The bacterial cell arrays 
were developed with Alexa fluor 488 labeled goat anti-mouse secondary antibodies (5 
µg/ml). The results are representative of three independent experiments (two slides for 
each experiment). The data points represent mean fluorescence value + SEM.  
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Figure 5. Antibody detection limit of bacterial cell arrays. Cell suspensions of Gram-
negative cells (A;  F.  tularensis and S. typhimurium) or Gram-positive cells (B; S. aureus 
and L. monocytogenes) were printed in replicates of ten spots on nitrocellulose coated 
slides. Slides were incubated with different concentrations of monoclonal antibodies (1, 
0.1, 0.01 and 0.001 µg/ml in PBS) specific for F. tularensis O-antigen (A) or L. 
monocytogenes cells (B). The arrays were developed with Alexa fluor 488 labeled goat 
anti-mouse secondary antibodies (5 µg/ml). The results are representative of three 
independent experiments. The data points represent mean ± SEM.  
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Figure 6. Francisella tularensis specific antibody detection in canine serum samples. 
An array of eight different bacteria (F. tularensis, S. typhimurium, E. coli, E. faecalis, K. 
pneumoniae, S. aureus, S. pyogenes and S. epidermidis) was printed in replicates of 
twenty spots on nitrocellulose slides and incubated with canine serum samples (dilution 
1:50) having a known microagglutination titer for F. tularensis antibodies. Seven positive 
(P1-P7; titer >20) and six negative serum samples (N1-N6; titer <20) were tested. Goat 
anti-canine secondary antibodies labeled with FITC were used at a concentration of 
5µg/ml. The levels of specific F. tularensis antibodies were significantly higher in 
positive samples (P 1 to 7) compared to negative samples (N 1 to 6). The results are 
representative of three independent experiments. The fluorescence signals for all samples 
were normalized as ratios of fluorescence signal from a canine serum sample (1: 50 
dilution) printed on the same slide and developed developed with FITC labeled anti-
canine antibodies after background substraction. The data points represent mean ± SEM. 
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CHAPTER VII 
CONCLUSIONS 
 
 
The purpose of the present study was to apply recent advances in molecular biology 
in developing novel methods for the detection of bacteria and diagnosis of bacterial 
infections. Specifically, the study attempted to adopt an in vitro selection process SELEX 
(Systematic Evolution of Ligands by Exponential Enrichment) for developing ssDNA 
aptamers against a surface target of Francisella tularensis as an alternative to antibodies. 
Further, microarray-based immunoassays were developed for the detection of antibodies 
to lipopolysaccharide (LPS), and bacterial surface antigens. The salient findings of the 
present study are 
• DNA aptamers were selected against the O-antigen of F. tularensis subspecies 
tularensis (Strain OSU10). A selected aptamer Ft1 showed specific binding to 
LPS of F. tularensis subspecies tularensis and subspecies holarctica. However, 
the aptamer did not show significant binding to whole cells of F. tularensis. This 
could be due to recognition of the core oligosaccharide part of LPS by the 
aptamer. The core oligosaccharide may not be readily accessible on the surface of 
bacteria for aptamer binding. Alternatively, use of whole cells in the selection 
process may help in developing aptamers to surface targets of bacteria.  
• The structure of the O-antigen of F. tularensis subspecies tularensis (strain OSU 
10) was analyzed by 1H- and 13C-NMR spectroscopy. The NMR data suggest that  
the O-antigen of F. tularensis subspecies tularensis strain OSU 10 has an 
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identical O-antigen as that of F. tularensis subspecies holarctica strain 15 and F. 
tularensis LVS. The O-antigen of these subspecies consist of repeating tetra-
saccharide subunits:  4-(α-D-GalpNAcAN-(1-4)- α-D-GalpNAcAN-(1-3)- β-D-
QuipNAc-(1-2)-β -D-Quip4NFo-1).  
• Lipopolysaccharide microarrays were developed for the detection of antibodies. 
LPS arrays will likely to find applications in disease diagnosis and 
seroepidemiology of Gram-negative bacterial infections. LPS arrays could be 
used in evaluation of intravenous immunoglobulin preparations for prophylactic 
or therapeutic use in endotoxemia/sepsis associated with Gram-negative bacterial 
infections and assessment of patients with sepsis/endotoxemia or patients prior to 
surgery.  LPS arrays may be useful in characterization of anti-LPS antibodies and 
other ligands.   
• Bacterial cell arrays were developed for the detection and characterization of 
antibodies to surface antigens. Bacterial arrays have potential use in disease 
diagnosis and seroepidemiology of bacterial infections. Further, bacterial arrays 
could find applications in screening of intravenous immunoglobulin preparations 
for the presence of pathogen specific antibodies for use in the treatment of 
bacterial infections and screening potential anti-adhesion therapeutics.  
 
Aptamers offer several advantages over antibodies. Although, a considerable progress 
has been made in case of aptamers as therapeutics, their potential in diagnostics yet has to 
be realized. Microarray based immunoassays are multiplex in nature allowing 
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simultaneous screening of a sample against multiple targets and require a small amount 
of reagents and samples. These assays have many potential applications including disease 
diagnosis and seroepidemiology. 
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